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HEMOGLOBIN AND THE HOST PATHOGEN INTERACTIONS IN STREPTOCOCCUS
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by

FAHMINA AKHTER

Under the Direction of Zehava Eichenbaum, PhD

ABSTRACT

Streptococcus pneumoniae is a principal human pathogen that colonizes the human
nasopharynx and causes a variety of diseases ranging from common infections to life-threatening
conditions such as pneumonia, meningitis, and sepsis. During infection, free iron is not available,
and thus, invading microbes, such as S. pneumoniae, compete with the host for the metal. The
heme-iron bound to hemoglobin is the most abounded form of iron in the human body. S.
pneumoniae can obtain iron from hemoglobin, but the bacterial mechanisms involved in this
process are only partially described. This dissertation investigated the role of hemoglobin in
pneumococcal physiology and virulence. The studies discovered that hemoglobin promotes
vigorous S. pneumoniae growth. The pneumococcal growth response is hemoglobin dependent,

conserved among pneumococcal serotypes, and not seen with free heme or iron. Hemoglobin also
induces an extensive transcriptome remodeling, effecting virulence factors and metabolism, and
in particular genes that facilitate the use of host glycoconjugates as a sugar source. The second
significant finding of this study is the discovery that hemoglobin promotes robust and early
pneumococcal biofilms. The biofilm response is hemoglobin specific, and free iron, heme, or other
heme sources such as myoglobin and serum do not induce the response. The addition of human
blood also triggers biofilms but required the pneumococcal hemolysin, Ply. S. pneumoniae cells
shifting from planktonic growth to biofilms in the presence of hemoglobin exhibit a significant
transcriptome shift that includes heme uptake and regulatory systems. The biofilm response to
hemoglobin involves the CiaRH two-component system, and the Competence Stimulating Peptide,
CSP-1. The data shows that CSP-1 functions in a new mechanism that is independent of its cognate
two-component system ComDE. In summary, this dissertation describes a novel role for the host
hemoglobin in pneumococcal physiology and pathogenesis. It discusses how these findings
advance the current understanding of S. pneumoniae interactions with its obligate human host.

INDEX WORDS: Streptococcus pneumoniae, Hemoglobin, Transcriptome, Host
glycoconjugates, Nasopharyngeal colonization, Biofilm, CSP, CiaRH.
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1

GENERAL INTRODUCTION

The purpose of this dissertation is to promote the understanding of the physiology and
virulence of the human pathogen Streptococcus pneumoniae (Spn). Experiments were centered on
heme uptake and pneumococcal adaptation to the host environment. This background section will
provide a brief overview of the area of pneumococcal pathogenesis and biofilm formation.

1.1

Streptococcus pneumoniae disease burden and vaccine

Spn is an obligate human pathogen that can be carried asymptomatically in the upper
respiratory tract [1]. Children are more common carriers of Spn than adults (20–50% and 5–20%,
respectively) depending on the sociodemographic status of the countries [2-4]. In some cases, the
pathogen migrates to lower airway or other anatomic sites and causes severe infections such as
otitis media, pneumonia, meningitis, and sepsis [5, 6]. Spn is the leading cause of bacterial
pneumonia, contributing to ~15 million annual cases worldwide and 800,000 deaths in children
(<5 years of age) [7, 8]. Pneumococcal pneumonia also increases the risk for the development of
cardiac diseases and heart failure [9, 10]. Hosts with under-developed or weak immune systems
such as infants, children under five years of age, elderly over 60-65 years of age, or with underlying
conditions are the most affected by Spn infections [5, 6, 11]. In addition, Spn coinfections with a
viral respiratory pathogen, such as Influenza A or the respiratory syncytial virus, worsen the
disease severity and mortality rates [12, 13]. A multivalent vaccine to combat pneumococcal
infections is available. But the vaccination program did not cover all the pneumococcal serotypes
and increased the prevalence of vaccine-escape serotypes. Hence, Spn remains a global threat [14].
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1.2

Spn virulence

Spn undergoes dynamic interactions with host cells employing a magnitude of virulence
factors from its initial establishment in the upper respiratory tract and through its spread within the
body [1, 15, 16]. The section below elaborates only on the virulence determinants that are
important for the experiments describe in this dissertation.

Nasopharyngeal colonization is critical for Spn virulence since it facilitates the pathogen
establishments within the host. Spn colonization requires bacterial factors that interact with host
epithelial surfaces, degrade the mucus, and promote the acquisition of essential nutrients such as
carbon source [17]. Sugars are not found in a free form in the upper respiratory tract [18, 19];
instead, they are linked to the proteins (and lipids) of the epithelial cell lining and mucin [20, 21].
To benefit from the host glycoconjugates, Spn employs several glycosidases, such as
Neuraminidase A (NanA), β-galactosidase (BgaA), and β-N-acetylglucosaminidase (StrH), which
sequentially cleave the sugars from host glycans [21-23]. Besides supplying Spn with carbon
sources, mucus degradation allows the bacteria to obstruct the mucociliary clearance. The
pneumococcal autolysin LytA, promotes the release of the pore-forming pneumolysin into the
extracellular environment. Ply, in turn, undermine the epithelial barriers and weaken ciliary
beating.

Several adhesins facilitate pneumococcal adherence to host surfaces. Spn attachment and
invasion proteins include the pneumococcal surface protein A (PspA), the fibronectin-binding
proteins, PavA and PavB, and pneumococcal histidine triad protein (Pht) [15, 17]. The cholinebinding proteins (CBPs) in Spn play an essential role in attachment and immune evasion. These
surface proteins can bind to phosphorylcholine residues on the pneumococcal cell wall and aid in
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host cell adherence [24]. CBPs can also obstruct the activation of the host complement system [15,
25]. Examples of CBPs essential for virulence include the pneumococcal surface protein A (PspA),
pneumococcal surface protein C (PspC), and LytA [15, 17].

Spn establishment of infection relies on the pathogen's ability to obtain essential nutrients
while in the host environment. Accordingly, many ABC importers are necessary for full virulence
[26-31]. These include transporters for peptides (e.g., Ami/Ali), sugars (e.g., MalX), and cations
such as zinc, manganese, and iron (e.g., Psa and Adc). Because of its role in this research project,
iron hemostasis in Spn is described in more detail in a separate section below. Interestingly, the
ligand-binding components of some transporters appear to have a dual role in infection; beside
nutrient acquisitions, these proteins contribute to processes such as signaling, resistance to
oxidative stress and adherence [15, 17, 28, 29].

1.3

Spn and iron

Iron is one of the most copious transition metals on earth and essential micronutrients for
nearly all forms of life. The metal is a co-factor for many enzymes involved in critical cellular
processes such as electron transport, photosynthesis, DNA synthesis, and translation. Under
normal physiological conditions, the iron in the mammalian body remains in the oxidized ferric
(Fe3+) form, which is highly insoluble, thus needs to be bound to carrier proteins [32]. To maintain
solubility, prevent toxicity, and restrict pathogen access, the mammalian host creates an ironlimited environment. Host proteins that have a high affinity for iron (for example, transferrin,
lactoferrin, and ferritin) sequester all of the metal in the body. Thus, iron bioavailability is
extremely low [10-18 M] in the host environment [33], while the growth of most bacteria demands
about 10-6 to 10-7 M of iron [34, 35].
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Most of the host-iron (67%) is found as heme, a heterocyclic ring that coordinates the metal
iron (Fe2+). Because of its lipophilic and pro-oxidant nature, heme can cause damage to cellular
components such as DNA, protein, and membrane [36-38]. Therefore, mammals limit free heme
in both circulation and the cellular compartment. Heme bound to hemoproteins is the primary iron
pool in the body [39, 40]. The erythrocytes hemoglobin is the most abundant hemoprotein [41],
and in healthy adults, its total blood concentration is approximately 1.9 to 2.3 mM [42].

Spn requires iron for growth, and like most pathogens evolved to scavenge the heme from
host hemoproteins [43]. At least three ABC transporters that facilitate iron uptake (i.e., Pia, Piu,
and Pit) were described in Spn [44-46]. Mutants in each system exhibit increased resistance to
streptonigrin, which indicates a reduction in the cellular iron levels [44, 45, 47], and the
contribution of these transporters to virulence was demonstrated in murine models [44]. The Pia
transporter is carried by a pathogenicity island [44]. PiaA, the ligand-binding-protein, binds
ferrichrome in vitro, and the structure of a PiaA-ferrichrome complex was resolved. [48].
Pneumococci, however, do not code for siderophore biosynthetic and secretion machinery [43,
49]. It is possible that Pia may function in the import of siderophores produced by the members of
the nasopharyngeal microflora. PiuA, the solute-binding protein of the Piu transporter, binds heme
and hemoglobin in vitro. A piu knockout mutant does not exhibit a defect in the use of hemoglobin
as an iron source. Still, a piu/pia double mutant is attenuated for growth on hemoglobin iron [47].
These findings imply that both systems contribute to heme uptake. Recently, another putative
lipoprotein SPD_1609 was implicated in iron-binding function like PitA [50, 51]. A knockout
spd_1609 mutant reduced adherence and invasion to host epithelial cells and decreased virulence
in a mouse bacteremia model [51]. Spbhp-37, is a ligand-binding protein that binds both heme and
hemoglobin with high affinity [52]. Spbhp-37 antiserum inhibits pneumococcal growth in the
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presence of hemoglobin as the sole source of iron. The cytoplasmic protein Spbhp-22 was
demonstrated to bind heme in vitro, and a mutant lacking this protein suffered from a reduced level
of iron. Nevertheless, the mechanism by which Spbhp-22 mediates iron uptake remains unclear
[53].

1.4

Biofilms in Spn disease

Upon colonization of the nasopharyngeal mucosa, pneumococcus forms organized
multicellular communities known as biofilms. Dense aggregates of bacteria produce the biofilm
matrix, which consists of proteins, DNA, and extracellular polysaccharides and facilitates
adherence to biotic and abiotic surfaces [54]. Both carriage and invasive pneumococci isolates
produce biofilm, and pneumococcal biofilms have been detected in vivo. For example, biofilms
were found the biopsy specimen of adenoid cells collected from children with chronic otitis media
[55], during chronic rhinosinusitis [56], and in cardiac microlesions [57]. The biofilm lifestyle
helps pneumococcus escape the host immune responses [54, 58], and provides opportunities to
naturally competent Spn to participate in unidirectional transformation and horizontal gene transfer
conferring antibiotic resistance and the rise in new capsular variants [59]. Interestingly, Studies in
Influenza A virus models suggest that altered nutrient availability in tissue prime pneumococci in
biofilms to shift into the invasive planktonic state [60].

Multiple pneumococcal products are known to involve biofilms formation in vivo. Sialic
acid was shown to act as a biofilm signal during colonization [61]. Accordingly, the pneumococcal
NanA, which cleaves the terminal sialic acid from host glycoproteins in the nasopharynx, was
found to play a vital role in nasopharyngeal biofilm formation [62]. An in vivo study in murine
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infection models demonstrated that the pneumococcal serine-rich protein, PsrP, is critical for Spn
persistence in the lower respiratory tract [63]. This protein facilitates intraspecies interactions that
foster biofilm formation in the nasopharynx and the lungs [64].
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CHAPTER 1: HEMOGLOBIN INDUCES GROWTH AND TRANSCRIPTOME
SHIFT IN STREPTOCOCCUS PNEUMONIAE: A NEW PARADIGM IN
PNEUMOCOCCAL HOST PATHOGEN INTERACTIONS
Streptococcus pneumoniae (Spn) must acquire iron from the host to establish infection. We

examined the impact of hemoglobin, the largest iron reservoir in the body, on pneumococcal
physiology. Supplementation with hemoglobin allowed Spn to resume growth in an iron-deplete
medium. Pneumococcal growth with hemoglobin was unusually robust, exhibiting an extended
logarithmic growth, higher biomass, and extended viability in both iron-deplete and standard
medium. We observed the hemoglobin-dependent response in multiple serotypes, but not with
other host proteins, free iron, or heme. Remarkably, hemoglobin induced a sizable transcriptome
remodeling, effecting virulence and metabolism in particular genes that facilitate host
glycoconjugates use. Accordingly, Spn was more adapted to grow on the human glycoprotein α-1
acid as a sugar source with hemoglobin. A mutant in the hemoglobin/heme-binding protein Spbhp37 was impaired for growth on heme and hemoglobin iron and exhibited reduced growth in THYB
supplemented with hemoglobin. In summary, the data show that hemoglobin is highly beneficial
for Spn cultivation in vitro and suggest that hemoglobin might drive the pathogen adaptation in
vivo. The hemoglobin receptor, Spbhp-37, plays a role in mediating the positive influence of
hemoglobin. These novel findings provide intriguing insights into pneumococcal interactions with
its obligate human host.
2.1

Introduction

Streptococcus pneumoniae (Spn) is a significant human pathogen that causes illnesses
ranging in severity from common otitis media infections to invasive diseases such as pneumonia,
bacteremia, and meningitis. Pneumococcal pneumonia is also a significant risk factor for the
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development of cardiac diseases and heart failure [9, 10]. Altogether, the toll of Spn on human
health is substantial, and the pathogen is responsible for ~15 million infections each year and about
half a million deaths in children worldwide [7, 8]. Pneumococci commonly colonize the human
nasopharynx and can persist asymptomatically for years in healthy individuals [1]. From the
nasopharynx, Spn can be transmitted among hosts [17] and spread to other organs. Young children
(<5 years of age), the elderly, and immunocompromised persons are the most susceptible
individuals to pneumococcal infections [5, 6, 11]. While colonization of the upper respiratory tract
is a pre-requisite for pneumococcal pathogenesis and infectivity, the factors that govern the
establishment of Spn in the human host and the pathogen’s transition into a virulent state, are not
fully appreciated.

Spn is a dangerous pathogen that thrives in its obligate human host. In vitro, however, this
fastidious bacterium exhibits relatively weak growth. Several studies were undertaken to optimize
streptococcal cultivation in a complex (e.g., Todd-Hewitt broth containing Yeast extract (THYB)
and tryptic soy broth) or defined media [65-67]. Pre-cultivation (i.e., inoculating with cells
collected from a logarithmic-phase culture), medium replenishment, and growth in bioreactors
with controlled growth parameters (such as pH and oxygen levels) were found to improve
pneumococcal growth, although often in a strain-dependent manner [65]. Inoculating THYB with
cells grown overnight in either broth or solid medium typically results in a long lag period that is
followed by a relatively short exponential growth. The culture enters the stationary phase with low
optical density (O.D.600 of 0.3 to 0.5, see references [45, 68] for examples). In addition to the
limited biomass, Spn cultures remain viable for a much shorter time when compared to other
bacteria. An autolysis mechanism that is activated upon entry into the stationary phase or in
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response to inhibition of the cell-wall synthesis is often responsible for the decreased viability
observed during in vitro cultivation. A threshold concentration of the extracellular amidase, LytA,
determines the onset of autolysis. During infection, however, the cell-wall degrading LytA is
needed for fratricidal lysis and virulence [69, 70]. The pneumococcal pyruvate oxidase, SpxB, and
its metabolic by-product H2O2 also contribute to pneumococcal killing during the stationary phase
of growth [71].

Within the human body, high-affinity proteins sequester iron and reduce the metal
bioavailability for invading microbes in a process called nutritional immunity. During colonization
and the courses of infections, pneumococci must gain access and retrieve the iron it needs for
growth from host proteins that carry heme or metal iron [72-74]. Most of the metal in the human
body is in heme within the erythrocyte hemoglobin (67% of the total body iron). Myoglobin and
cytochrome represent most of the remaining heme pool (3.5 and 3 %). Iron is also highly
sequestered in the extracellular compartment. The serum proteins hemopexin and transferrin
respectively remove the small amounts of free heme and iron in the serum. The host lactoferrin
sequesters ferric ions from secretions and near the infection site. Spn readily grows on heme or
hemoglobin iron [43] but is unable to obtain the metal from transferrin and lactoferrin [43]. The
pneumococcal mechanisms that facilitate the capture and uptake of heme are only partially
understood [75, 76]. The ABC transporter PiuBCDA (also known as Pit1BCDA) is the only
recognized heme importer in Spn. PiuA, the ligand-binding component, binds heme and
hemoglobin in vitro, and inactivation of the piuBCDA genes partially impairs Spn growth on heme
iron. [47]. Spbhp-37, is the second substrate-binding protein in Spn that interacts with hemoglobin
and heme [52]. Spbhp-37 antiserum inhibits pneumococcal growth on hemoglobin iron. However,
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a mutant in spbhp-37 was not described, and it’s not known which transporter works with this
substrate-binding protein for heme import. A recent report implicated an additional Spn protein,
Spbhp-22, in iron uptake. In vitro assays showed that Spbhp-22 binds heme, but the mechanism
by which this cytoplasmic protein promotes iron or heme intake remains unclear [53]. Since
hemoglobin is the primary source of an essential nutrient during infection, we hypothesized that
hemoglobin is vital for pneumococcal pathophysiology.

2.2

Materials and Methods

2.2.1 Bacterial strains and growth media

The Spn strains used in this study are listed in Table 2.1. Frozen Spn stocks were prepared
in the medium Skim milk-Tryptone-Glucose-Glycerin (STGG) as described [77] and kept at -80
°C. Spn STGG stocks were plated on Tryptic Soy blood agar plates (BAPs) and incubated
overnight at 37°C under microaerophilic conditions. Spn was also grown in Todd-Hewitt broth
containing 0.5% (w/vol) Yeast extract (THYB) or in Casein-Tryptone (CAT) medium [78]
containing Bacto Casitone 10 g/l, Bacto Tryptone 10 g/l, Yeast extract 1 g/l, NaCl 5 g/l, 0.5M
K2HPO4 (30 ml/l) and 200 U/µl of catalase. One or more of the following supplements were added
to the growth medium as indicated: The iron chelator 2, 2’-Di-pyridyl (Acros organics), bovine
hemin (Sigma Aldrich), human hemoglobin (Sigma Aldrich), Ferric nitrate nonahydrate (FeNO3,
Fisher Scientific), bovine serum albumin (BSA, Sigma Aldrich), 200 U/µl of catalase (Sigma
Aldrich), glucose (Sigma Aldrich), human α-1 acid glycoprotein (AGP, Sigma Aldrich), or fattyacid free human serum albumin (Sigma Aldrich). Some experiments used frozen logarithmic Spn
stocks as the starting inoculum. To prepare such stocks, Spn cells growing in THYB were collected
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at the early logarithmic phase of growth (O.D.600 = 0.2-0.3), and glycerol was added to the culture
to a final 10% (vol/vol) and stored at -80 °C.

2.2.2 The growth assays

Fresh medium (with or without supplements) was inoculated with Spn cells collected from
BAPs following overnight incubation (starting O.D.600 = 0.05) or from frozen logarithmic culture
(starting culture O.D.600 = 0.02) as indicated. Cell cultures (200 l per well) were allowed to grow
in 96-well microtiter plates (Corning) incubated at 37 ˚C. The culture O.D.600 was recorded at
1hour intervals for 18 hours using a SpectraMax M2 spectrophotometer (Molecular Device). For
each growth condition, we used wells containing only the medium (and supplements when
appropriate) as the blank. Bacterial growth was tested in triplicates. To determine cell viability,
culture samples were collected at designated time points, serially diluted in 0.9% saline, and plated
in triplicates into BAP.

2.2.3 Total iron determination by ICP-MS

Fresh THYB medium containing 80 µM FeNO3 or 20 µM hemoglobin was inoculated with
Spn grown on BAPs (starting O.D.600 = 0.05) and incubated at 37 C for 6 h in 12 well microtiter
plates. Culture samples (6 ml, O.D.600 = 1) were washed three times with phosphate-buffered saline
(PBS) prior to collection. The cell pellet was digested and analyzed (Center for Applied Isotope
Studies, University of Georgia, Athens, GA) as described [79, 80].
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2.2.4 Construction of Δspbhp-37 mutant

The plasmids used in this study are listed in Table 2.1 and the primers in Table 2.2. We
cloned a spbhp-37 mutant in Spn strain D39 by replacing the spbhp-37 coding sequence with that
of ermB (erythromycin resistance [81]), such that the ermB ORF is under the transcriptional
control of spbhp-37 promoter and terminator. The mutant allele containing ermB ORF flanked by
the 5’ and 3’ genomic regions of the spbhp-37 gene was prepared using the Gene art seamless
cloning kit (Thermo fisher scientific). Briefly, the appropriate genomic segments were amplified
from D39 chromosome using the primer sets ZE 740-L/ZE 741-R and ZE 744-L/ZE 745-R. The
ermB gene and the pUC19 vector were amplified from pCR2.1 topo and pUC19-L plasmids using
the primer sets ZE 742-L/ZE 743-R and ZE 738-L/ZE 739-R, respectively. All PCR fragments
were purified (using the Minelute PCR purification kit, Qiagen) and cloned into One-shot topo E.
coli strain, generating plasmid pAF104. The resulting allele was then amplified (from pAF104)
and transformed into competent D39 cells using standard protocols [82]. The mutants were
selected on BAPs containing erythromycin (0.5 µg/ml). The mutation was confirmed by PCR in
the resulting erythromycin-resistant clones using the primer set ZE 740-L/ZE 745-R.
2.2.5

Spn growth with human α-1 acid glycoprotein and serum albumin

To remove contaminating free sugars, human α-1 acid glycoprotein (AGP, 10 mg/ml) was
dialyzed in water using Slide-A-Lyzer dialysis cassette G2 (10,000 molecular weight cutoff,
Thermo scientific) as described [22]. The samples were then concentrated with Amicon Ultra
centrifugal filters (MWCO 10,000), reconstituted in CAT medium (5 mg/ml) and filter sterilized.
Spn D39 grown overnight on BAP were collected, washed and suspended in CAT. These cell
suspensions were used to inoculate fresh CAT medium with or without glucose (0.5% (w/v), AGP
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(5 mg/ml) or HSA (20 M). Bacterial growth in the presence or absence of 20 M hemoglobin in
96-well microtiter plates was monitored as described above.

2.2.6 RNA-Seq analysis

Fresh THYB was inoculated with Spn cells from frozen logarithmic stocks (starting culture
O.D.600 = 0.02) and the cultures were allowed to grow in 12 well microtiter plates (2 ml per well)
at 37 C. 20 µM Hb (in 0.9% saline) or 0.9% saline (negative control) was added to the growing
cells at the early logarithmic phase (O.D.600 = 0.2-0.3). Cultures samples (four biological replicates
for each condition) were collected and mixed with RNA protect reagent (Qiagen) following
manufacturer’s recommendations. Cells were then collected by centrifugation and stored at -80
°C. For RNA preparation, cell samples were suspended in 700 μl of Trizol with 300 mg of acidwashed glass beads (Sigma Life Science) and disrupted by vortexing. Total RNA was isolated
using the Direct-zol RNA MiniPrep kit (Zymo Research). DNA was removed using the Turbo
DNase-free kit (Life Technologies). rRNA was eliminated with the Ribo-Zero Magnetic kit for
Gram-positive bacteria (Epicenter). RNA Quality and quantity were assessed using a 2100
Bioanalyzer (Agilent) and NanoDrop 8000 spectrophotometer (Thermo Scientific), respectively.
Directional RNA-Seq libraries were created using the ScriptSeq v2 RNA-Seq Library Preparation
kit (Illumina) according to the manufacturer’s instructions. A rapid-run 100 bp single-read DNA
sequencing was performed at the Institute for Bioscience and Biotechnology Research (IBBR)
Sequencing Facility at the University of Maryland, College Park, using the Illumina HiSeq 1500
platform. Data were generated in the standard Sanger FastQ format and raw reads were deposited
with the Sequence Read Archive (SRA) at the National Center for Biotechnology Institute
(accession PRJNA626052). Read quality was evaluated using FastQC software (Babraham
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Bioinformatics), and mapping against the Spn D39 genome using Bowtie package alignment
software [83]. The read count or raw count data for all genes were acquired using Feature count
package [84]. These raw count data files were then used in DESeq2 package [85] to calculate
differential expression analysis of all samples for pairwise comparison. Graph Pad Prism (version
8.3.1) was used to prepare dot plot representation of gene expression levels using normalized
RNA-seq read counts.

2.2.7 qRT-PCR analysis

Quantitative reverse transcription PCR (qRT-PCR) analysis was carried out using the
Power SYBR® Green RNA-to-Ct™ 1-Step Kit (AB) and 7500 Fast Real-Time PCR machine (AB)
according to the manufacturer’s specifications. A total of 25 ng RNA was used per qRT-PCR
reactions and each reaction was done in duplicates. Primers used for qRT-PCR are listed in Table
2. The relative expression was normalized to the endogenous control gyrB gene and fold changes
were calculated using the comparative 2-ΔΔCT method.
2.3

Results

2.3.1 Hemoglobin stimulates unusually robust growth of Spn in batch cultures

To test the use of hemoglobin iron by Spn, we adopted the growth assay from our studies
with the related Group A Streptococcus [86]. We cultivated Spn in fresh THYB, with or without
the iron chelator 2, 2’-Di-pyridyl (DP) and different iron supplements (Fig. 2.1). Spn did not grow
in THYB-DP, but growth was restored when we complemented the medium with ferric iron ( 
0.5 mM, Fig. 2.1A), demonstrating that DP prevents pneumococcal cultivation by limiting iron
bioavailability. Supplementation with hemoglobin (Fig. 2.1B) or heme (Fig. 2.1C) also supported
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Spn growth in THYB-DP in a dose-dependent manner. Higher amounts of FeNO3 compared to a
heme source (mM vs. M, respectively) were needed to support growth, because DP chelates metal
iron but not heme [86, 87]. Surprisingly, hemoglobin facilitated a much better growth THYB-DP
compared with free iron (Fig. 2.1B). In the presence of hemoglobin, the culture displayed only a
brief lag phase, which was followed by a prolonged (and somewhat bi-phasic) exponential period,
reaching a higher maximal optical density. Free heme also supports Spn growth in THYB-DP, but
growth was not as robust as with hemoglobin, and heme became a growth-inhibitory above ten
µM (Fig. 2.1C).

Spn growth in THYB-DP with hemoglobin ( 5 µM) exceeded the one observed in
standard medium (THYB, Fig. 2.1A & B). We tested the impact of adding 0.5 - 20 µM hemoglobin
to iron complete THYB. Remarkably, hemoglobin stirred vigorous growth in a dose-dependent
manner (Fig. 2.2A). Incubation with 20 µM serum albumin, which has a similar molecular weight
(~60 kDa), resulted only in a minimal growth improvement (Fig. 2.2B). Supplementation with
hemoglobin that was heat-inactivated did not promote growth. To rule out the possibility that a
contaminant in our hemoglobin preparation was responsible for the observed enhanced growth,
we filtered the hemoglobin solution using 10,000 MW cutoff and tested both fractions for growth
impact. The filtered hemoglobin retained activity while the flow-through was somewhat growthinhibitory (Fig. 2.2B). It seemed possible that the positive growth induced by hemoglobin results
from the intrinsic peroxidase activity of hemoglobin [88], leading to protection from hydrogen
peroxide [89]. To test this hypothesis, we grew Spn in THYB and added catalase to scavenge
hydrogen peroxide. Results in Fig. 2.2C demonstrate that supplementation with catalase had a
minimal impact on Spn cultivation.
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Supplementation with an equimolar amount of iron (10-80 µM FeNO3, each hemoglobin
molecule has four heme groups) did not have a significant effect (Fig. 2.2D). The addition of free
heme to THYB did not improve growth at the low µM range and was inhibitory above ten µM
(Fig. 2.2E). To evaluate whether the enhanced growth was due to an improved uptake of iron when
pneumococci are incubated with hemoglobin, we measured intracellular iron levels by ICP-MS
(Fig. 2.2F). Equal amounts of iron were found in cells grown in THYB or THYB with 20 M
hemoglobin. Surprisingly, supplementation with 80 M FeNO3 resulted in an actual reduction in
the total iron cellular level.

We next tested the viability of cells at different time points during growth in THYB with
and without 20 µM hemoglobin. Consistent with the higher optical density, in the presence of
hemoglobin, viable count at 8-hour post-inoculation was about twice as that determined for
cultures grown without hemoglobin (Table 2.3). Cells exhibited a sharp decline in viability after
overnight incubation (18 hours) in both THYB and THYB with hemoglobin. However, 18-fold
more viable cells were obtained in cultures grown with hemoglobin compared to cultures
cultivated in THYB alone (Table 2.3, 18 h). In summary, hemoglobin-induced growth and viability
are a hemoglobin-dependent phenomenon observed in both iron-deplete and iron-complete
medium.
2.3.2 Hemoglobin modulates Spn growth independently of the strain and the growth assay

Next, we asked if the response to hemoglobin is widespread among pneumococcal strains,
and thereby tested the impact of hemoglobin on TIGR4 and two clinical isolates. These
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experiments revealed that hemoglobin stimulated growth in all three strains (Fig. 2.3A). The
positive impact of hemoglobin might only be seen in our experimental system whereby Spn are
grown on blood agar plates prior to inoculating THYB. To examine if this is the case, we
inoculated fresh THYB with an overnight culture grown in THYB (Fig. 2.3B). Compared to cells
collected from BAPs, bacteria that came from liquid culture (in THYB) exhibited a more
prolonged lag phase and yielded lower final biomass. Nonetheless, the addition of hemoglobin still
significantly improved the second round of growth in THYB in these cells. We next used frozen
logarithmic cells grown in THYB to start new THYB cultures with and without hemoglobin (Fig.
2.3B). Inoculating the medium with logarithmic cells abolished the lag phase and improved overall
growth. Still, supplementation with hemoglobin enhanced growth even further compared to THYB
alone. We also tested the effect of hemoglobin on pneumococcal growth in casein tryptone (CAT)
medium. When we inoculated CAT medium with Spn cells collected from BAPs, the bacterial
growth was comparable to the one seen in THYB inoculated with cells from BAPs. The addition
of hemoglobin to CAT, however, altered the bacterial growth pattern and yield. In the presence of
hemoglobin, the pneumococci exhibited only limited growth for the first six hours in CAT. This
initial phase was followed by extended exponential growth that resulted in higher biomass
compared to pneumococci growing in CAT only (Fig. 2.3C). In summary, hemoglobin
dramatically impacts growth in batch cultures of multiple pneumococcal strains regardless of the
assay, or media used.

2.3.3 Hemoglobin induced a sizable transcriptome remodeling

Since hemoglobin has a considerable influence on growth, we asked how it may affect
pneumococcal gene expression. Hemoglobin or saline (as a control) was added to Spn cultures
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grown in THYB at the early log phase and culture samples were collected one- and two-hours
post-treatment. RNA was isolated from four biological replicates for each growth condition and
analyzed by RNA-Seq. This global transcriptome study revealed that the addition of hemoglobin
to the growth medium resulted in a significant shift in gene expression. 59 Spn genes were
upregulated and 18 genes were down-regulated (at least two folds) in response to hemoglobin
within one hour (Fig. 2.4A & B), and a total of 100 and 45 genes were induced or repressed
respectively two hours post-treatment. qRT-PCR on a subset of regulated genes validated the RNA
seq findings (Appendix A).

Many of the genes that were differentially expressed in response to hemoglobin are related
to the import and biosynthesis of nucleotides, amino acids, fatty acids, and lipids (Fig. 2.5).
Notably, hemoglobin activated the transcription of several metabolic genes and genes encoding
virulence factors needed for Spn nasopharyngeal colonization and infections. These include the
genes of the oligopeptide-binding proteins, aliA and aliB [28], the PGN hydrolase, lytB [90], the
gene encoding the pneumococcal histidine triad protein D, phtD [91] and the surface adhesin, pavB
(Fig. 2.5A) [92]. Hemoglobin also repressed many metabolic genes of which, it is noteworthy that
the whole operon coding for proteins of a heme importer, piuBCDA, was downregulated by
incubation with hemoglobin (SPD_1649-52, Fig. 2.5B) [44]. The expression of the
heme/hemoglobin binding protein, spbhp-37, which also promotes Spn use of hemoglobin iron
[52, 93], was high but not differentially expressed (Fig. 2.5C).

Many of the hemoglobin-responding genes are related to carbohydrate intake and
conversion (Fig. 2.6). The bgu operon [94] encoding a lactose type phosphotransferase system
(PTS) (SPD_1830-33) exhibited the most robust induction post hemoglobin addition (6-fold and
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16-25-fold in the first and second hours respectively, Fig. 2.6A). In vitro, this PTS system mediates
the use of beta-glucosides such as amygdalin or cellobiose [95]. During infection, however, βlinked disaccharides found in glycosaminoglycans of the host extracellular matrix are the proposed
substrates of the bgu PTS. Other hemoglobin responding loci involved in carbohydrate metabolism
include the lacABCD genes (SPD_1050-54, the tagatose pathway enzymes), bgaA and bgaC
enzymes, and the associated galactose and mannose type PTS systems (SPD_0559-62 and 006771 respectively). A mannose-type PTS system (SPD_0293-5) that is involved in the use of
sulfated-glycosaminoglycan (e.g., hyaluronic acid) [95] was upregulated in second hour of
hemoglobin treatment (Fig. 2.6A). In contrast, hemoglobin downregulated the expression of the
ABC transporter (rafGFE) that imports the trisaccharide raffinose and of a glycerol facilitator (Fig.
2.6B).

2.3.4 Hemoglobin promotes pneumococcal growth on host glycoconjugates in vitro

Since hemoglobin induced the expression of PTSs and enzymes that are known or predicted
to be involved in the use of host glycans, we hypothesized that hemoglobin enhances the ability of
Spn to use these host molecules as nutrients. To test this hypothesis, we examined the impact of
hemoglobin on Spn growth on the human -1-acid glycoprotein, AGP (N-linked glycan, Fig.
2.7A). Spn growth in CAT medium (which contains glucose) was similar to that seen in THYB
(Fig. 2.3C). The removal of the glucose from the CAT broth, however, impeded growth (Fig.
2.7B). Spn grew rapidly when the sugar-free CAT was supplemented with both AGP and
hemoglobin, but not in sugar-free CAT medium supplemented with either AGP or hemoglobin
individually (Fig. 2.7B). The addition of human serum albumin as a control did not promote
growth in sugar-free CAT with or without AGP (Fig. 2.7C). These data indicate that hemoglobin
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promotes pneumococcal use of AGP in vitro and suggests it may enhance the use of host
glycoproteins as a carbohydrate source in vivo.

2.3.5 A spbhp-37 deletion mutant exhibits a lessened growth response to hemoglobin
Although hemoglobin stimulates Spn growth in both iron-complete and iron-deplete
THYB, it still seemed possible that the positive influence of hemoglobin is related to its ability to
donate heme. THYB supplementation with hemoglobin repressed transcription of the heme
importer genes piuBCDA, allowing for only very low expression (Fig 2.5C). The expression of
spbhp-37, the second heme/hemoglobin receptor with a role in heme uptake, however, was high
(with and without hemoglobin Fig. 2.5C). In silico analysis predicted that Spbhp-37 is expressed
as a monocistronic mRNA [96]. To see if Spbhp-37 plays a role in the response, we generated a
deletion mutant (replacing spbhp-37 ORF with that of ermB) and tested its impact on hemoglobin
growth induction (Fig. 2.8). The spbhp-37 mutant was not able to grow in THYB-DP
supplemented with free heme and exhibited growth attenuation when grown in THYB-DP
supplemented with hemoglobin (Fig. 2.8A). The mutant also had a growth phenotype in THYB
alone. Although spbhp-37 growth was improved in the presence of hemoglobin, it was still
reduced compared with the wild type strain (Fig. 2.8B). ICP-MS analysis demonstrated a
significant reduction in total iron levels in the spbhp-37 compare with the parental strain in cells
grown in THYB with 20 M hemoglobin (Fig. 2.8C). These observations confirm a role for Spbhp37 in iron uptake and imply that this hemoglobin/heme-binding protein plays some role in the Spn
growth response to hemoglobin.
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2.4

Discussion

In this study, we demonstrated that hemoglobin, a host hemoprotein, has a substantial
impact on Spn physiology and planktonic growth. The data reveal that the presence of hemoglobin
greatly benefits pneumococcal growth and viability in complex laboratory media, redirecting the
pneumococcal transcriptome and metabolic capacity. This appears to enhance the ability of Spn to
use host glycoproteins as a source of carbohydrates, providing a potential fitness advantage during
colonization and infection. The data also suggest that the heme uptake protein, Spbhp-37, plays a
role in the positive influence of hemoglobin on Spn physiology. Below we discuss how these
intriguing findings advance our current understanding of Spn interactions with its obligate human
host.

Hemoglobin facilitates vigorous growth in iron-depleted medium. The reinstatement of
Spn growth in the iron-depleted medium, THYB-DP, by hemoglobin or heme (Fig. 2.1B & C)
shows that Spn can metabolize heme iron, as it was previously reported [43, 44, 52]. Hemoglobin
iron, however, appears particularly beneficial, triggering strong Spn growth surpassing that seen
with free iron or heme alone (Fig. 2.1). This is the first report to describe the unusually robust
growth of Spn upon hemoglobin supplementation in an otherwise iron-deplete medium. Why had
other investigators not seen this exquisite hemoglobin-specific enhanced growth? Technical
differences, such as the use of the chelating resin, Chelex-100, might have masked the positive
impact of hemoglobin in prior investigations [43, 44, 52]. Chelex-100 has broad specificity, and
treatment with this resin might have limited the availability of additional cations that are needed
for full Spn growth. Furthermore, the long pre-cultivation in iron-deprived medium prior to the
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addition of hemoglobin used in some studies [52], might also have limited maximal growth with
hemoglobin.

THYB-DP supplemented with heme above 5-10 M (equivalent to 20-40 M hemoglobin)
was growth inhibitory. In excess, heme is harmful to many bacteria, including the related
Streptococcus pyogenes, due to its lipophilic and oxidative nature, which damages the bacterial
membranes, proteins, and nucleic acids [97, 98]. The negative impact that is inherent to the
presence of free heme in the medium may prevent the benefit of heme that is provided by
hemoglobin. Hemoglobin likely delivers the heme directly to surface receptors and membrane
transporters for import [47, 93, 99]. Compared to free heme, heme that is delivered from one
protein to another likely has fewer opportunities to damage the cell envelope.

Spn growth stimulation is hemoglobin-dependent and utilizes a unique mechanism.
Supplementing THYB with hemoglobin enhances pneumococcal growth, shortening the lag
period, and increasing maximal biomass and viability (Fig. 2.2A & B and Table 2.3). Other host
proteins, inactivated hemoglobin, or the flow-through collected after hemoglobin filtration, did not
have this effect. Hence, it is hemoglobin in its native form, rather than a nonspecific increase in
peptides and amino acids availability, or the presence of low molecular weight contaminants, that
is advantageous for Spn growth. Spn is often grown with a source of catalase (e.g., blood) to
neutralize a large amount of hydrogen peroxide this bacterium can produce. If inhibition of H2O2
by hemoglobin allowed enhanced growth, then the addition of catalase to THYB would have
improved growth, but this did not occur (Fig. 2.2C), suggesting that hemoglobin does not extend
growth by scavenging the H2O2 from the medium.
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Supplementation with ferric iron did not enhance Spn growth in THYB, suggesting that
the iron levels in this medium are not growth-limiting for Spn (Fig. 2.2D). Moreover, the cellular
levels of iron in cells grown in THYB with hemoglobin are similar to those found in cells grown
in regular THYB (Fig. 2.2F). Therefore, hemoglobin growth benefits are not derived by facilitating
an increase in the total iron level in Spn. Hemoglobin, however, might have increased the cellular
heme-to-iron ratio compared with cells that grew in THYB. Hence, we speculate that hemoglobin
promotes growth, at least in part, by donating heme and that heme is more growth beneficial then
metal iron. The finding that Spn imports less of the metal when THYB is enriched with ferric iron
(Fig. 2.2F) supports the idea that heme might be more useful for the pathogen’s physiology than
free iron. Other pathogenic bacteria such as Staphylococcus aureus and S. pyogenes demonstrate
a preference for heme when supplied with both free iron and heme [100, 101]. Canonical heme
degradation results in the production of biliverdin and its reduced product bilirubin [102], both
molecules scavenge various ROS and are considered potent antioxidants [103, 104]. Perhaps,
similar to the human host, heme catabolism by Spn leads to the production of protective end
products and thus is valuable beyond iron release. Studies in our laboratories are underway to
address this hypothesis.

The positive response to hemoglobin was rigorously assessed in the current study and
found to be shared by multiple pneumococcal strains and independent of the growth assay used
(Fig. 2.3). The addition of hemoglobin shortens the lag period in THYB inoculated with overnight
cultures that grew either on BAPs or in THYB (Fig. 2.3B). Nevertheless, cells that were collected
from BAPs exhibited improved growth. It’s possible that the presence of hemoglobin is one of the
growth-promoting factors in BAPs, which are commonly used for Spn cultivation. Notably, the
addition of hemoglobin to THYB inoculated with logarithmic cells still enhanced growth (Fig.
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2.3B). Hence, hemoglobin acts by both stimulating growth in resting cells and by extending the
growth period before an exponentially growing culture enter the stationary phase. Spn growth with
hemoglobin appeared biphasic in all conditions, other than in cultures inoculated with logarithmic
cells. The formation of a two-step growth curve was more apparent in the experiments using Spn
grown on THYB as the inoculum (Fig. 2.3B), in CAT medium (Fig. 2.3C), and with the spbhp37 mutant (Fig. 2.8A & B). We have not explored in detail this biphasic growth pattern. Still, the
absence of the first growth phase in cultures using logarithmic cultures implies that the initial
hemoglobin impact on resting cells can be separated from its influence on exponentially growing
cells.

It is not fully understood why Spn exhibits limited growth in batch cultures and enters early
into the stationary phase. Acidification and other growth conditions were implicated as growth
limiting factors. Nevertheless, at least some Spn strains (such as D39), still demonstrated limited
exponential growth even under conditions where the pH and other factors such as temperature and
atmosphere were controlled [65, 105]. The data here show that hemoglobin extends Spn growth in
medium that was not otherwise replenished, without pH control, with or without pre-cultivation.
Therefore, it’s possible that hemoglobin (directly and/or via the heme it donates) redirects a
regulatory mechanism(s) that otherwise leads to premature growth arrest during in vitro
cultivation. Interestingly, hemoglobin did not influence the expression of lytA and spxB, which
cause Spn death, but the expression of these two genes was high under our experimental conditions
(Fig. 2.6C). It is worth noting that for our transcriptome studies hemoglobin was added at the early
exponential growth, and gene expression was analyzed one and two hours after treatment; thus,
we can’t rule out a later change in lytA and spxB expression.
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Hemoglobin has a broad impact on Spn transcriptome suggesting host adaptation.
Hemoglobin triggered significant transcriptome remodeling (Fig. 2.4). Various genes with an
established role in colonization were activated (Fig. 2.5A), including the aliA/aliB genes. The
lipoproteins, AliA, and AliB, are paralogs of AmiA, the oligopeptide-binding component of the
Ami system, which is used by the auxotroph Spn to import oligopeptides. [106]. Inactivation of
ami-aliA/aliB attenuates adherence to pulmonary epithelial cells [107], and these proteins are
important for the initial colonization of the nasopharynx [28]. Hemoglobin also induced the PGN
hydrolase gene, lytB, whose activity is necessary for the adherence and invasion of human lung
epithelial cells [90]. The colonizing factor PavB also positively responded to hemoglobin. PavB
contributes to nasopharyngeal colonization and is highly expressed during heart infection [57, 92].
Similarly, hemoglobin induced the arginine biosynthesis genes, argGH, which are needed for
growth in the lung, blood, and cerebrospinal fluids [108]. Hence, Spn transcriptome response to
hemoglobin suggests the pathogen perceives the presence of hemoglobin as a cue for the host
environment.

Hemoglobin activates pneumococcal utilization of glycoproteins found in the host
mucin and the epithelial mucosa. Hemoglobin had a strong influence on the expression of many
genes involved in the uptake and use of host-derived sugars found in the mucosa and extracellular
matrix (Fig. 2.6). Spn can ferment about 32 different carbohydrates in vitro [95], and over 30% of
the transporters in the Spn genome are dedicated to carbohydrate uptake [49], many of which
contribute to colonization and pathogenesis. Free sugars, however, are not typically available in
the upper respiratory tract [18, 19]; rather, they are linked to the glycoproteins (i.e., O- and Nlinked glycan and glycosaminoglycan) found on the epithelial cell lining and in mucin [20, 21].
Sequential deglycosylation by various pneumococcal exo-glycosidases (e.g., BgaA, BgaC, NanA,
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NanB and StrH) allow Spn to cleave the sugars from the host glycan for uptake ([21-23] and Fig.
2.7A). Our transcriptome analysis suggests that hemoglobin activates the expression of genes
needed for the release, import, or catabolism of the host glycan derived monosaccharides,
galactose and mannose, glycosaminoglycan disaccharides (e.g., hyaluronic acid), and the betaglucosides amygdalin and cellobiose (Fig. 2.6A). Therefore, like mucin [109], hemoglobin induces
the expression of Spn genes required for growth on sugars derived from the host glycans. In vitro
growth assays confirmed that Spn could use the human -1-acid glycoprotein AGP (N-linked
glycan) as a carbohydrate source when grown in the presence of hemoglobin (Fig. 2.7B), but not
in the presence of human serum albumin, HSA, as a control (Fig. 2.7C). Hemoglobin
downregulated the operons encoding the glycerol MIP family transporter, glp, and the raffinose
transporter (Fig. 2.6B). Interestingly, Spn ear isolates demonstrate a reduced capacity to use the
sugar raffinose comparing with blood isolates [110].

The hemoglobin/heme receptor Spbhp-37 has a redundant role in mediating the
hemoglobin growth benefits. PiuA and Spbhp-37 are the only two hemoglobin (and heme)
receptors with an established role in heme uptake. Hemoglobin, however, represses expression of
the piuBCDA transporter, while the expression of spbhp-37 remained high whether hemoglobin
was added or not (more than 30-fold above piuA, Fig. 2.5C). Using a spbhp-37 mutant, we
showed that Spbhp-37 plays an important role in the use of heme and hemoglobin iron (Fig. 2.8A).
This is consistent with the observation that inhibition of Spbhp-37 by antibody interfered with Spn
growth on hemoglobin iron [52]. Spn, however, was still able to utilize hemoglobin, likely due to
redundancy in heme uptake systems. Notably, the spbhp-37 mutant did not grow well in THYB,
the addition of hemoglobin improved growth only partially, and lower iron levels were found in
mutant cells grown in THYB with hemoglobin (Fig. 2.8C). Together, these observations suggest
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that Spbhp-37 has a redundant role in mediating the growth benefit of hemoglobin, possibly by
capturing heme from hemoglobin.

Spn is listed as a severe threat in the 2019 CDC antimicrobial-resistant (AMR) report [111].
Therefore, it is critical to gain insights into Spn pathophysiology to better design new treatment
modalities. Herein, we have demonstrated that hemoglobin greatly benefits pneumococcal
cultivation in vitro, promoting growth and viability, and causes a transcriptome shift that is likely
to advance Spn preparation for colonization and infection. Hence, this study makes significant
contributions to the understanding of pneumococcal growth requirements and adaptation to its
obligate human host. Additional work is needed to describe the mechanism by which Spn perceives
and responds to hemoglobin and the effect of hemoglobin on Spn during infection.

Figure 2.1: Hemoglobin-dependent growth of Spn D39 in iron-deplete medium.
THYB was inoculated with D39 cells grown on BAPs (18 h, starting O.D.600 = 0.05).
Shown is growth in (A) THYB, THYB with 3mM di-pyridyl (DP), THYB with DP and 0.5 - 3
mM of FeNO3 (Fe); (B) THYB with DP supplemented with 0.5 µM -20 µM hemoglobin (Hb); and
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(C) THYB with DP supplemented with 5 - 60 µM heme (Hm). The data are representative of three
independent experiments performed in triplicates; error bars indicate SD.

Figure 2.2: Hemoglobin stimulates a robust growth of Spn D39 in standard (iron-complete)
medium.

THYB was inoculated with D39 cells grown on BAPs (18 h, starting O.D.600 = 0.05. Shown
is growth in (A) THYB with 0 - 20 µM hemoglobin (Hb); (B) THYB with 20 µM BSA, denatured
hemoglobin, filtered hemoglobin, or the flow-through; (C) THYB with or without catalase. (D)
THYB supplemented with 0 - 80 µM FeNO3 (Fe); (E) THYB with 0 - 40 µM heme (Hm). The
data are representative of three independent experiments performed in triplicates; error bars
indicate SD. (F) Total intracellular iron content measured by ICP-MS in culture samples
(normalized to optical density) grown in THYB, THYB with 20 µM hemoglobin (Hb), or THYB
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with 80 µM FeNO3 (Fe). The data represents the average of three independent biological replicates;
error bars indicate SD.

Figure 2.3: Hemoglobin stimulates Spn growth independently of the strain or the growth assay.
Shown is Spn growth in fresh THYB (empty symbols) or THYB with 20 µM hemoglobin
(full symbols). The culture starting O.D.600 is indicated. (A) TIGR4 (red), and the clinical isolates
3875 (blue), and 8655 (yellow) grown on BAPs (18 h) was used as the inoculum (O.D.600 = 0.05).
(B) THYB was inoculated with D39 cells from frozen logarithmic cultures (O.D.600 = 0.02, red),
THYB cultures (18 h, O.D.600 = 0.05, blue), or cell from BAPs (18 h, O.D.600 = 0.05, green). (C)
D39 growth in CAT medium (empty symbols), CAT medium with 20 µM hemoglobin (red, full
symbols) or 20 µM human serum albumin (green, full symbols). The data are representative of
three independent experiments performed in triplicates; error bars indicates SD.
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Figure 2.4: The addition of hemoglobin to the culture medium triggers a significant
transcriptome remodeling in Spn.

Venn diagram (using R) of differentially expressed genes in D39 culture (fold change ≥ 2).
(A) Genes upregulated by hemoglobin. (B) Genes downregulated by hemoglobin.
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Figure 2.5: Hemoglobin activates Spn genes vital for host colonization.

The relative expression of genes involved in metabolism, nutrient uptake, virulence, or
regulation, at 1 h and 2 h post hemoglobin addition (Y-axis) is plotted for D39 genes (X-axis). (A)
Up-regulated genes. Stripes indicate involvement in nasopharyngeal colonization. (B) Downregulated genes. (C) Dot plot representation of gene expression levels depicting normalized RNAseq read counts (Y-axis) for cells with 1h post-treatment. Genes encoding heme/hemoglobin
binding (red) or virulence factors (blue) are highlighted.
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Figure 2.6: Hemoglobin up regulates Spn genes involved in host glycoconjugate use.

Log2-fold changes in gene expression levels (Y-axis) is plotted for D39 genes (X-axis). (A)
PTSs, enzymes and hypothetical protein (HP). (B) down regulated sugar transporters.
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Figure 2.7: Hemoglobin facilitates Spn growth on a human glycoprotein.

(A) Schematic representation of the human -1-acid glycoprotein (AGP), as described in
[22]. Arrows indicate the cleavage sites of the Spn enzymes, neuraminidase (NanA), galactosidase
(BgaA), and N-acetylglucosaminidase (StrH). Fresh medium was inoculated with D39 grown on
BAPs (18 h, starting O.D.600 = 0.05). (B) Shown is Spn growth in sugar-free CAT medium (no
glucose added), or sugar-free CAT with 5 mg/ml AGP, and/or 20 µM hemoglobin (+Hb). (C) The
same as in (A), only that 20 µM human serum albumin (+HSA) was added instead of hemoglobin.
The data are representative of three independent experiments performed in triplicates; error bars
indicate SD.
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Figure 2.8: The heme/hemoglobin binding protein, Spbhp-37, plays a role in mediating the
positive impact of hemoglobin in Spn.

Fresh medium was inoculated with D39 (blue) and the isogenic Δspbhp-37 strain (orange)
grown on BAPs (18 h, starting O.D.600 = 0.05). Shown is growth in (A) THYB with 3mM dipyridyl (DP), THYB with DP and 10 M heme or 20 M hemoglobin, or (B) THYB (empty
symbols) or THYB with 20 µM hemoglobin (full symbol). The data are representative of three
independent experiments performed in triplicates; error bars indicate SD. (C) Total intracellular
iron content (ppm) determined by ICP-MS in D39 wild type and Spbhp-37 mutant cultures samples
(normalized to optical density) grown in THYB with 20 µM hemoglobin. The data represents the
average of three independent biological replicates; error bars indicate SD.
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Table 2.1: Strains and plasmids used in this study.

S. pneumoniae
D39

Description
Avery strain, clinical
isolate, WT (capsular
serotype 2), CSP1

Source or references
[112], [113]

TIGR4

Invasive clinical isolate,
WT (capsular serotype 4),
CSP2

[49]

8655

Invasive isolate (serotype
6B), CSP2
Invasive isolate (serotype
6B), CSP1

CDC

D39-derivative spbhp-37
null mutant, Eryr

This study

Cloning strain

Invitrogen

Seamless cloning vector
pUC19, Ampr
Cloning vector, Eryr

This study

3875

∆spbhp-37

CDC

E. coli
One shot Top-10
Plasmids
pAF104
pCR2.1 TOPO

[81]
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Table 2.2: Primers used in this study.
Target
pUC19-L

Primers
Sequence (5′ to 3′)
Comments
ZE 738-L TATCAAAGGGCATGCAAGCTTGGCGTAATCAT cloning
ZE 739-R ACTGTGCAGTACCGAGCTCGAATTCACTGGCC

5′- region
of spbhp37

ZE 740-L CTCGGTACTGCACAGTAGTAGGTTTCCCTTTG
ZE 741-R TTGTTCATTACTGAACCTCCTAAATAAGATGT

ermB

ZE 742-L GTTCAGTAATGAACAAAAATATAAAATATTCT cloning
ZE 743-R CATCAAGGCGACTCATAGAATTATTTCCTCCC

3′- region
of spbhp37

ZE 744-L ATGAGTCGCCTTGATGGAAGCGTAAAAGTTCC
ZE 745-R TGCATGCCCTTTGATAGACAAAACCACTTCTT

cloning

aliB

ZE 878-L GGACTGTTTCTCAGGACGGTTTG
ZE 879-R CAGCTGCATATTGCAAACCTGTC

qPCR

ilvD

ZE 880-L CCTGGTATGCGTTTCTCTCTAAC
ZE 881-R AGCAATCATAGATCCAGGCATG

qPCR

aliA

ZE 882-L GGTCACTTATGGGGATGAATGG
ZE 883-R GGAATGTCACACCTTCTGCTTG

qPCR

argG

ZE 884-L CCTTGGTATCTGCCTTGAGC
ZE 885-R GATCCAAGGCTGCAATCGATAC

qPCR

cloning

SPD_1803 ZE 886-L GGATTGGATGAGGATTTCTACC
ZE 887-R CTTCTCTAACAAGCCAAGACATG

qPCR

gyrB

qPCR

ZE 661-L GGCACTGTATGGTATCACACAAG
ZE 662-R TCTCTAAATTGGGAGCGAATGTC
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Table 2.3: Effect of hemoglobin supplementation on Spn viability.
* NS denotes THYB without supplements, Hb denotes THYB supplemented with 20 M
hemoglobin. Statistical analysis: 8h, P = 0.02; 18h, P = 0.04 (Student t test)

Incubation time (h)
8

18

Conditions*

Total (CFU/ml)

NS

2.6 ± 1.3 X 108

Hb

5.5 ± 1.1 X 108

NS

4.7 ± 3.1 X 102

Hb

8.5 ± 6.4 X 103
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CHAPER II: HEMOGLOBIN INDUCES ROBUST STREPTOCOCCUS

PNEUMONIAE BIOFILMS VIA THE CSP AND CIARH PATHWAYS: A NEW
REGULATORY RIDDLE
Biofilm formation is a crucial stage in the nasopharyngeal establishment and disease
progression by the human pathogen Streptococcus pneumoniae. In vitro, the biofilms pneumococci
produce on abiotic surfaces exhibit delayed growth, lower biomass, and lack the structures seen in
biofilms grown on epithelial cells or during nasopharyngeal colonization. Herein, we show that
the addition of hemoglobin to the medium activates unusually robust and early biofilms in multiple
S. pneumoniae serotypes grown in batch cultures on abiotic surfaces. Supplementation with
denatured hemoglobin, myoglobin, free iron, or heme, did not induce biofilms. Pooled human
blood, but not serum, also stimulated biofilms. A mutant in the pore-forming pneumolysin, ply,
lost the biofilm response to blood but not to hemoglobin. S. pneumoniae transitioning from
planktonic growth into biofilms in the presence of hemoglobin displayed an extensive
transcriptome remodeling. In addition to many changes, we noticed the activation of heme uptake,
bacteriocin immunity, and regulatory pathways, including the ciaRH and comCDE systems.
Inactivation of ciaRH or comC genes resulted in a corresponding reduction of 37% and 67% in
biofilm formation respectively. The deletion of comD or comE, however, had little or no effect on
biofilms, respectively. In summary, hemoglobin promotes vigorous pneumococcal biofilms in
vitro. This response requires the ciaRH and comC genes. The competence stimulating peptide,
CSP-1, functions independently of its cognate two-component system, comDE, in promoting
biofilms in the presence of hemoglobin. Altogether, these findings provide new and intriguing
insights into the interactions between S. pneumoniae and its obligate human host.
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3.1

Introduction

Streptococcus pneumoniae (Spn) colonizes the nasopharyngeal mucosal surfaces.
Asymptomatic carriage facilitates dissemination from person to person and the development of
several clinical manifestations, including invasive diseases such as pneumonia, meningitis, and
bacteremia. Spn causes 15 million cases of severe infections each year, leading to proximately half
a million deaths in children [7, 8]. Resistance to beta-lactams, macrolides, or tetracycline was
reported in more than 30% of invasive pneumococcal disease in 2017 [114, 115], leading the
World Health Organization to classify Spn in 2017 as one of the top twelve priority pathogens
[111, 114, 115].

Spn carriage in the upper respiratory tract and lungs involves the formation of bacterial
aggregates developed into biofilms. Pneumococcal biofilms have also been detected in chronic
otitis media infection [55] and rhinosinusitis [56]. Local spread and bronchoaspiration may lead
Spn to breach the epithelial and endothelial barriers and penetrate tissues, providing access to the
bloodstream. Recently, pneumococcal biofilms were described in cardiac microlesions after Spn
invasion of the myocardium [57]. Biofilms not only help pneumococci compete with the native
flora and serve as reservoirs for pneumococcal spread, but these bacterial structures also assist in
the escape from the host immune responses and confer antibiotic resistance [54, 58].

The first in vitro model system for pneumococcal biofilm used cellulose Sorbarod filters
as the surface, was developed to study antibiotic susceptibility [116]. Since then, several advanced
in vitro model systems for Spn biofilms were developed by us and others. These biofilm models
include static or continuous flow bioreactors with live cultures of respiratory or mucosal epithelial

40
cells [117-120]. Spn produces pronounced biofilm structures in these tissue culture models [64,
118, 120-122]. Still biofilm formation on abiotic surfaces requires the growth medium to be
replenished, logarithmic culture as the inoculum, or the addition of the competence signaling
peptide (CSP) to the growth medium. Even with these conditions, pneumococcal biofilms typically
develop in batch cultures only after 16-24 hours of incubation [123, 124]. Multiple conditions,
such as media type, pH, temperature, and osmolality, influence pneumococcal biofilm formation
in vitro [54]. Moscoso et al., for example, observed robust biofilms in chemically defined or semisynthetic media, while pneumococci growing in complex media such as CAT or Todd-Hewitt
Broth with 5% yeast extract, produced poor biofilms [123].

The role of several bacterial factors in pneumococcal biofilms was established. For
example, both sialic acid and choline residues (on the cell-wall teichoic acids) have a positive
influence on biofilm development [61]. Hence, inactivation of the neuraminidase nanA [119] and
several genes encoding choline-binding proteins [123, 125] attenuates biofilms. Capsule
production, however, is adversarial to biofilm formation in Spn [125, 126]. Both of the two
quorum-sensing systems, Lux and Com, contribute to pneumococcal biofilms [127]. Investigations
in model systems, involving abiotic surfaces and human respiratory cells, show that the
autoinducer, LuxS (AI-2), is needed in the early stages (24 h post inoculation) of biofilms
formation. The luxS mutant produced ~80% less biofilm biomass comparing to the wild type strain
[120]. The competence stimulating peptide-1 (CSP-1), on the other hand, does not impact the
initial attachment of cells to the surface in a microtiter model but promotes stability and maturation
of biofilms on abiotic surfaces [124, 128] and in a bioreactor model with human respiratory
epithelial cells [120]. The two-component system (TCS) ciaRH facilitates pneumococcal stress
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response and resistance to antibiotics that target the cell wall. The expression of the response
regulator, ciaR is induced during biofilm growth [124], and insertion mutants in the histidine
kinase, ciaH, were isolated by in vitro screen for biofilm-attenuated mutants [125, 126]. In vivo,
the ciaRH genes are required for the Spn establishment and biofilm formation in the nasal septa in
a murine model [125, 126]. In summary, biofilm development by Spn is multifactorial, and
multiple regulatory circuits influence it.

In vivo, biofilms play a vital role in pneumococcal establishment in the upper respiratory
tract, ears, lungs, and heart. The host factors that promote the pneumococcal interchange between
the planktonic and sessile states are not fully appreciated. We recently discovered that the addition
of hemoglobin to the culture medium triggers growth as well as an extensive transcriptome shift
that includes many metabolic genes and virulence factors necessary for nasopharyngeal
colonization and lung infections (manuscript under review). We, therefore, tested here the
hypothesis that hemoglobin also promotes pneumococcal biofilms.

3.2

Materials and Methods

3.2.1 Bacterial strains and growth conditions

The Spn strains used in this study are listed in Table 3.1. Frozen Spn stocks were prepared
in the medium Skim milk-Tryptone-Glucose-Glycerin (STGG) as described [77] and kept at -80
°C. Spn STGG stocks were plated on Tryptic Soy blood agar plates (BAPs) and incubated
overnight at 37°C under microaerophilic conditions. Spn was also grown in Todd-Hewitt broth
containing 0.5% (w/vol) Yeast extract (THYB). One or more of the following supplements were

42
added to the growth medium as indicated: The iron chelator 2, 2’-Di-pyridyl (Acros organics),
bovine hemin (Sigma Aldrich), bovine serum albumin (BSA, Sigma Aldrich), human hemoglobin
(Sigma Aldrich), Ferric nitrate nonahydrate (FeNO3, Fisher scientific), equine myoglobin (Mb)
(Sigma Aldrich), whole human blood (BioIVT), human serum (Innovative Research), and
competence stimulating peptide (CSP1, 200 ng/ml) (Annaspec). The antibiotic erythromycin (ery;
0.5 µg/ml), chloramphenicol (Cm; 4 µg/ml), and tetracycline (tet, 1 µg/ml), was added to the BAP
when needed. In some experiments, heat-inactivated hemoglobin (at 99°C for 5 min) and filtered
hemoglobin (using Amicon Ultra centrifugal filters, MWCO 10,000), or the flow-through fraction
was added to the growth medium.

3.2.2 The growth assays

Fresh medium (with or without supplements) was inoculated with Spn cells collected from
BAPs following overnight incubation (starting culture O.D.600 = 0.05). Cell cultures (200 l per
well) were allowed to grow in 96-well microtiter plates (Coaster 3595, Corning) incubated at 37
˚C. The culture O.D.600 was recorded at 1 h intervals for 18 h using (SpectraMax M2
spectrophotometer, Molecular device). For each growth condition, we used wells containing only
the medium (and supplements when appropriate) as the blank. Bacterial growth was tested in
triplicates.

3.2.3 Biofilm assay on abiotic surfaces

To monitor Spn biofilm formation, an overnight BAP culture (starting culture O.D.600 =
0.05) was used to inoculate into fresh THYB media (with and without supplement). The culture
was grown in microtiter plate for indicated times at 37 ˚C statically. We performed crystal violet
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staining to quantitate the biofilm biomass. In brief, the planktonic cultures were removed from the
plate and biofilms were washed five times with double-distilled water (ddH2O) and then allowed
to dry for 15 min. Crystal violet (0.1%) was then added, and the biofilms were incubated for 15
min with slow shaking (Lab-Line Maxi Rotator). After washing 4 to 5 times, crystal violet-stained
biofilms were allowed to dry at room temperature for 15 min. To quantify biofilm biomass, crystal
violet was dissolved by adding 95% ethanol to each well including the blank well and incubated
for 15 min at room temperature followed by mixing the suspension by pipetting vigorously. The
absorbance at 590 nm of solubilized dye was determined in a SpectraMax M2 spectrophotometer
(Molecular device). To determine biofilm cell viability at designated time points, biofilm cells
were washed twice with sterile phosphate-buffered saline (PBS) and the plates were sonicated for
15 seconds in a Cole-Parmer ultrasonic cleaner followed by vigorous pipetting to collect all
attached bacteria. Biofilm cell counts (CFU/ml) were determined by dilution plating into BAP.

3.2.4 Visualizing Spn biofilm by confocal microscopy

To test the surface specificity for biofilm production, we used an 8-well glass plate as
another abiotic surface. An overnight BAP culture of GFP-expressing D39 was used to inoculate
the glass plate in a similar method as above. Spn biofilms produced on 8-well glass plate for
indicated time points (at 2h, 4h, 6h and 8h) were washed three times with PBS, fixed with 2%
paraformaldehyde and stained as previously described [120]. Briefly, the capsules were stained
with wheat germ agglutinin conjugated with Alexa Fluor 555 (Molecular Probes, Invitrogen) for
30 min. Nucleic acids were stained with TO-PRO-3 (Molecular Probes) for 15 min. All staining
procedures were performed at room temperature. Finally, after washing three times with PBS, the
preparations were mounted with Vectashield mounting medium (Vector Laboratories) and
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analyzed with a Zeiss LSM 510 confocal microscope. Confocal images were analyzed with LSM
Image Browser, version 4.0.2.121.).

3.2.5

Spn growth analysis using human blood and serum ex-vivo

We prepared 0.1%, 0.3%, and 0.5% suspension in sterile phosphate buffered saline (PBS)
from whole human blood. Then the suspension was washed three times by centrifuging at 500xg
for 5 min at 4˚C in each washing step. Finally, resuspended in fresh THYB media and proceeded
with inoculation into microtiter plate with Spn culture using procedures described above. Normal
pooled human serum (ranges from 2.5% to 40%) was added to the THYB media followed by filter
sterilized the mixture and used in microtiter growth assay. Following overnight growth in a
microtiter plate, biofilm formation was assayed using the crystal violet staining method described
above.

3.2.6

RNA-Seq analysis

Fresh THYB was inoculated with Spn cells from frozen logarithmic stocks (starting culture
O.D.600 = 0.02), and the cultures were allowed to grow in 12 well microtiter plates (2 ml per well)
at 37 C. 20 µM hemoglobin (in 0.9% saline) or 0.9% saline (negative control) was added to the
growing cells at the early logarithmic phase (O.D.600 = 0.2-0.3). To harvest biofilm samples,
planktonic cultures were washed once with sterile 1xPBS (1ml) and added 1ml PBS to each well
followed by sonicating the plates for 15 s. Samples of biofilm cultures were collected and
processed with RNA protect reagent (Qiagen) following the manufacturer’s recommendations and
stored the pellet at -80°C until further use. For RNA preparation, cell samples were suspended in
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700 μl of Trizol with 300 mg of acid-washed glass beads (Sigma Life Science) and disrupted by
vortexing. Total RNA was isolated using the Direct-zol RNA MiniPrep kit (Zymo Research). DNA
was removed by the Turbo DNase-free kit (Life Technologies). rRNA was eliminated with the
Ribo-Zero Magnetic kit for Gram-positive bacteria (Epicenter). RNA Quality and quantity were
assessed using a 2100 Bioanalyzer (Agilent) and NanoDrop 8000 spectrophotometer (Thermo
Scientific), respectively.

Directional RNA-Seq libraries were created using the ScriptSeq v2 RNA-Seq Library
Preparation kit (Illumina) according to the manufacturer’s instructions. A rapid-run 100 bp singleread DNA sequencing was performed at the Institute for Bioscience and Biotechnology Research
(IBBR) Sequencing Facility at the University of Maryland, College Park, using the Illumina HiSeq
1500 platform. Data were generated in the standard Sanger FastQ format and raw reads were
deposited with the Sequence Read Archive (SRA) at the National Center for Biotechnology
Institute. Read quality was evaluated using FastQC software (Babraham Bioinformatics), and
mapping against the Spn D39 genome using Bowtie package alignment software [83]. The read
count or raw count data for all genes were acquired using Featurecount package [84]. These raw
count data files were then used in DESeq2 package [85] to calculate differential expression
analysis of all samples for pairwise comparison.

3.2.7 Construction of D39-derived mutant strains

The plasmids used in this study are listed in Table 3.1 and the primers in Table 3.2. To
prepare a deletion mutant in ciaRH, yesMN and vicK genes in the background of Spn D39 strain,
the mutant alleles containing the ermC gene or cat-194 gene (which confers resistance to
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erythromycin, eryR and chloramphenicol, CmR respectively) flanked by the 5’ and 3’ genomic
regions of either ciaRH or yesMN or the vicK genes were prepared using the Gene art seamless
cloning kit (Thermo fisher scientific). Briefly, the appropriate genomic segments were amplified
from the D39 chromosome using the primer sets indicated in table 3.2. The ermC gene, cat-194
and the pUC19 vector were amplified from pJRS233, pDC123 and pUC19-L plasmids using the
primer sets described in table 3.2, respectively. All PCR fragments were purified (using the
Minelute PCR purification kit, Qiagen) and cloned into One-shot topo E. coli strain, generating
plasmid pAF105, pAF106 and pAF108. The resulting allele was then amplified (from pAF105,
pAF106 and pAF108) and transformed into competent D39 cells using standard protocols [82].
The mutants were selected on BAPs containing erythromycin (0.5 µg/ml) or chloramphenicol (4
µg/ml). The mutation was confirmed by PCR in the resulting erythromycin-resistant clone (named
2F45 and 2F26) and chloramphenicol-resistant clone (named 2F22) using the primer set ZE 776L/ZE 781-R, ZE 800-L/ZE 805-R, ZE 784-L/ZE 789-R respectively.

3.3

Results

3.3.1 Hemoglobin induces a rapid formation of Spn biofilms in vitro

We recently observed that the addition of hemoglobin to an iron-deplete medium facilitates
vigorous pneumococcal growth that exceeded the one observed in the presence of free iron. Heme
also supports Spn growth but is toxic above 10 M. Notably, we noted growth stimulation also
when a standard Todd-Hewitt and yeast extract broth (THYB) was supplemented with hemoglobin
but not with free iron or heme (manuscript under review). Here, we examined the impact of
additional host heme sources. THYB containing the iron chelator DP was inoculated with Spn
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D39, and the cultures were allowed to grow in microtiter plates for 18 h (Fig. 3.1). Pneumococcal
did not grow in THYB-DP, but the addition of 20 M myoglobin or serum (5-40 % V/V) reinstated
growth (Fig. 3.1A and data not shown). Growth with myoglobin or serum surpassed the one
observed with free iron or heme (Fig. 3.1A). Notably, these heme sources also allowed for better
Spn growth in THYB (iron-complete) (Fig. 3.1B). Similar to hemoglobin, Spn cultivation in
THYB is stimulated by myoglobin and serum, although not to the same extent as with hemoglobin.

Crystal violates staining (18 h) revealed Spn D39 produced biofilms in the presence of
hemoglobin in either standard THYB (Fig. 3.2A) or iron-deplete medium (THYB-DP, Fig. 3.2B).
Biofilm induction by hemoglobin occurred in a dose-dependent manner, starting with 0.5 µM
hemoglobin in THYB (Fig. 3.2A) or 5 µM in THYB-DP (Fig. 3.2B). We did not observe biofilm
formation with myoglobin, heme, or free iron. Similarly, the addition of a control protein (BSA,
which has a molecular weight similar to hemoglobin) or denatured hemoglobin did not stimulate
biofilm. To exclude the possibility that a contaminant in our hemoglobin preparation was
responsible for triggering biofilms, we filtered the hemoglobin solution using 10,000 MW cutoff
and tested both fractions. While filtered hemoglobin induced biofilms, the flow-through did not
(Fig. 3.2C). Finally, hemoglobin induced biofilms also in six different Spn vaccine strains,
including reference strain TIGR4 and EF3030 and clinical isolates (Fig. 3.2D and data not shown).
Therefore, biofilm induction is dependent on hemoglobin in its native form and conserved in
multiple serotypes.

Following biofilm formation, over time, we found that pneumococci that grew in THYB
supplemented with hemoglobin formed significant biofilm biomass as early as 6 hours post-
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inoculation and generated most of the biomass within 8 hours of incubation (Fig. 3.3A). In contrast,
the controls (THYB) produced little to no biofilms in THYB up to 48 h of incubation. Using viable
counts, we found that 3.6-fold more live cells were recovered from the microplate surface in the
presence of hemoglobin compared to cultures that grew in THYB alone (2.2 ± 0.57 x 108 Vs. 6.1
± 1.94 x 107 respectively, P = 0.05) (Table 3.3). We also used a more sensitive, fluorescent-based
method and confocal microscopy to investigate the timing of biofilm formation. The growth of
GFP-expressing D39 was visualized by staining the bacterial capsule and DNA. Confocal images
(XY optical sections) revealed a rapid formation of biofilms that started at 2 h post-inoculation
and plateau at 8 h when D39 was incubated with Hb (Fig. 3.3C).

3.3.2 Human erythrocytes trigger biofilm formation in a Ply-dependent manner

Under physiological conditions, most of the hemoglobin is within the blood erythrocytes.
We next examine the impact of supplementing the growth medium with blood. The addition of
washed blood cells (0.1 - 0.5%) to THYB triggered robust Spn growth in the two test strains (D39
and TIGR4, data not shown). Biofilm biomass also significantly increased when pneumococci
were incubated with blood cells, although to a lower level compared to hemoglobin (Fig. 3.4A).
Pneumolysin (Ply) releases hemoglobin from blood cells in vitro [129-131]. Hence, we asked if
this hemolysin is needed the biofilm response. A ply knockout in both D39 and TIGR4
backgrounds did not produce biofilms when grown in THYB supplemented with blood. On the
other hand, the ply mutants produced robust biofilms in response to hemoglobin (Fig. 3.4B). While
the addition of human serum to THYB also enhanced Spn growth (Fig. 3.1B), THYB
supplementation with serum (2.5 – 40 %) did not trigger biofilms (Fig. 3.2A, data not shown).

49
Hence, labile hemoglobin released from erythrocytes by Ply is likely responsible for signaling Spn
biofilms.

3.3.3 Spn transitioning to biofilm in the presence of hemoglobin exhibits a significant
transcriptome shift

We next examine global gene expression in Spn transitioning into biofilm in the presence
of hemoglobin. Hemoglobin or saline (as a control) was added to Spn cultures grown in THYB at
the early log phase, and culture samples were collected one- and two-hours post-treatment. RNA
was isolated from four biological replicates for each growth condition and analyzed by RNA-Seq.
The global transcriptome in planktonic Spn was compared to that in sessile cells (recovered from
the microtiter surface). Note that Spn did not produce biofilms when grown in THYB under our
experimental conditions; hence we could not compare gene expression among biofilm cells growth
with and without hemoglobin. The comparison between planktonic and early biofilms cells (both
with hemoglobin, two biological replicates) revealed a significant transcriptome shift that took
place mostly within the first hour after hemoglobin addition. 322 and 136 genes were
correspondently up- and down-regulated in the first hour after treatment (Fig. 3.5A & B). To adjust
to biofilm growth, Spn differently expresses metabolic pathways and reduces the expression of
genes involved in translation and transcription [132]. We observed a similar response during
growth in early biofilms in the presence of hemoglobin (Fig. 2.6). For example, many PTS systems
and other genes related to carbohydrate metabolism were repressed in sessile cells in the presence
of hemoglobin. These include the bgu (SPD_1830-33) and lacABCD (SPD_1050-54) operons.
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The transition from planktonic growth to biofilms in the presence of hemoglobin was
associated with the induction of several genes whose expression is induced during infection and
are vital for biofilm formation in vivo (Fig. 3.6A). These genes include nanA, neuraminidase that
catalyzes the release of terminal sialic acid residues from the host glycoconjugates. The
transcription of the nanA genes is activated during lung infection, and this enzyme is essential for
Spn biofilm formation in the nasopharynx [62]. Compared to planktonic cells, Spn in early biofilm
exhibited higher expression of the heme importer, piuBCDA, and the operon encoding spbhb22,
which is implicated in heme uptake [53] (SPD_1590, Fig. 3.6A). The ferrochrome-binding protein,
piaA, was, on the other hand, repressed in the surface attached cells (Fig. 3.6B).

The transition from planktonic growth to biofilms in the presence of hemoglobin was
associated with the induction of quorum sensing systems, two-component systems (TCS), and
putative regulators. For example, the signaling peptide, phrA was activated together with the
associated lantibiotic-synthesis gene cluster encoded by the Region of Diversity 12 (RD12 [133,
134], Fig. 3.6A). Notably, the TrpA/PhrA-controlled gene cluster is not expressed in vitro (in
regular laboratory medium), but its transcription is activated during heart infection [57]. The
lantibiotic-immunity genes, blpYZ were also induced in biofilm-forming pneumococci, as well as
several genes from the com regulon (i.e., comCDE, comAB, amiEDCA, cbpD, and cinA). In
addition to comDE, the two-component systems (TCSs) yesMN, ciaRH, vicRK and liaSR, were
also induced (Fig. 3.6A), reflecting the complexity of the biofilm response to hemoglobin.

3.3.4 Biofilm formation in the presence of hemoglobin require comC and ciaRH genes
To test for a possible role in the biofilm response to hemoglobin, we tested mutants in
regulatory genes that were up regulated in pneumococci that are transitioning into biofilms in the
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presence of hemoglobin. Deletion mutant in comC (encoding CSP-1 peptide), and TCS ciaRH,
yesMN, and in the histidine kinase vicK (vicR is an essential gene) were examined in biofilm
production (Fig. 3.7). All the tested mutants produce significant biofilms when grown in the
presence of hemoglobin compared to growth in standard THYB (18 h, Fig. 3.7A). No significant
difference in biofilm biomass generated by the yesMN and vicK mutants compared to the
parental D39 strain when grown in THYB with hemoglobin (Fig. 3.7A). Inactivation of ciaRH or
comC, however, resulted in 37% (P = 0.01) and 67% (P = 0.001) reduction in biofilm biomass,
respectively. Since the inactivation of comC was the most detrimental for biofilms development
in our experimental conditions, we also tested individual deletions in the histidine kinase comD
and the response regulator, comE, which mediates CSP-1 signaling. Surprisingly, the deletion of
comD resulted in a 20% (P = 0.04) reduction in biofilm production, while the deletion of comE
had no impact (Fig. 3.7B). Supplementing the medium with CSP-1, corrected the phenotype
observed with the comC and comD strains, but had no significant influence on biofilm
production by the comE or ciaRH mutants. Together, the data demonstrate that both comC and
ciaRH genes are involved in biofilm production in the presence of hemoglobin and that comC
orchestrate the response almost completely independently of comDE.

3.4

Discussion

Environment sensing is essential to the transition of biofilm-forming microbes from a
planktonic to a sessile state. The corresponding transcriptome adjustment guides the global
physiological and metabolic changes that take place during biofilm development, from the initial
attachment up to biofilm maturation. Spn is a colonizer of the upper respiratory tract, who is well
adapted to its obligate human host. The host factors that play a role in biofilm formation during

52
colonization in Spn are not fully appreciated [3, 15, 17, 54, 127]. Our group recently discovered
that the addition of hemoglobin to the medium activates the expression of many pneumococcal
genes with an established role in colonization. Here, the data show that hemoglobin induces early
and robust pneumococcal biofilm structures that are typically not observed in abiotic models in
vitro. Spn transitioning into biofilms with hemoglobin exhibit an extensive transcriptome shift,
activating genes that are typically expressed in vivo during biofilm growth. The pneumococcal
biofilm response to hemoglobin is mediated by a new mechanism that involves the comC and
ciaRH genes. Below we discuss these intriguing observations and the implication on the current
understanding of pneumococcal physiology and virulence.

Spn biofilms formed on abiotic surfaces typically exhibit a delayed growth and lower
biomass compared with biofilms growth on epithelial cells or in the nasopharynx in vivo [118, 119,
135]. Moreover, non-encapsulated strains produce more biofilm than encapsulated strains [123,
125]. Surprisingly, the addition of hemoglobin to THYB, as the sole iron source or as a supplement,
triggered a dose-depended biofilm formation in several encapsulated strains, including vaccine
serotypes (Fig. 3.2D). In the presence of hemoglobin, biofilm development was unusually early
(within 2 - 8 h of incubation) compared to typical in vitro models (which takes 18-24 h [127]) and
vigorous leading to considerable biomass and structures (Fig. 3.3).

Ferric iron (~50 M) induced a significant increase of Spn biofilms in C+Y medium [136].
Under our experimental conditions, iron did not influence biofilm formation, perhaps because of
the different growth conditions (THYB vs. C+Y). Likewise, the addition of free heme, myoglobin,
or serum had no impact on biofilm formation (Fig. 3.2A & B), supporting the notion that
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hemoglobin induction of biofilms is not solely due to the ability of hemoglobin to donate iron or
heme. Moreover, myoglobin and serum did not induce biofilms, although they promoted more
vigorous growth in THYB and THYB-DP (Fig. 3.1). These observations suggest that the influence
of hemoglobin on pneumococcal growth (which might be related to the heme it carries) is separated
from its impact on biofilm formation.

Supplementation with a control protein (BSA) or the flow-through after hemoglobin
filtration did not promote biofilms (Fig. 3.2C), showing that biofilm signaling is not triggered by
non-specific addition of peptides or the presence of possible contaminants. Heat inactivation
diminished hemoglobin activation of biofilms. While serum did not induce biofilms, washed blood
cells promoted pneumococcal biofilms in wildtype Spn but not in a ply mutant (Fig. 3.4A), the
mutant, however, produced biofilms in response to the presence of hemoglobin (Fig. 3.4B).
Therefore, its labile hemoglobin released from erythrocytes by Ply that is inducing biofilms in the
presence of blood. Together, the data show that hemoglobin, in its native form, signals biofilm
formation in Spn by an unknown mechanism. The data also imply that the biofilm response to
hemoglobin can take place in vivo when Spn encounters blood.

In general, we found that the transcriptome of Spn cells transitioning into biofilms in the
presence of hemoglobin had the hallmarks of a typical transcriptome of pneumococcal cells during
biofilm growth [124] (Fig. 3.6). Few noteworthy examples of Spn gene expression pattern during
biofilm growth are virulence gene, nanA and regulators, comE, ciaR, and mgrA [124]. Remarkably,
among the highly transcribed genes under our growth conditions, we found the virulent
determinants (from the core pneumococcal genome) that are strongly expressed by Spn when
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grown in biofilm in the heart. These include spxB (pyruvate oxidase), pspA (pneumococcal surface
protein A), pavB (pneumococcal adhesion and virulence protein B), zmpB (zinc metalloprotease
B), lytA (autolysin), ply (pneumolysin), and pcpA (pneumococcal choline-binding protein A). The
spx gene, whose expression was amongst the highest, is needed for Spn biofilm formation both in
vivo and in vitro, possibly by driving the formation of biofilm required products [126, 137].

Transcriptome studies revealed the induction of several regulatory systems in early
biofilms cells, hence, implicating them in the biofilm response to hemoglobin (Fig. 3.6A). The
mutant analysis demonstrated a role only for comC and ciaRH genes (Fig 3.7). These findings are
consistent with the part in biofilm development reported previously for both regulatory circuits
[124-126, 128]. The comC gene orchestrates competence development in Spn by activating the
ComD histidine kinase, which relays the signal to the ComE response regulator, which in turn
activates the com regulon (including the comCDE operon [138]). The data show that inactivation
of comC resulted in the biggest loss of biofilm formation in Spn grown with hemoglobin (Fig.
3.7A), and this phenotype was complemented by the external addition of CSP-1. Interestingly,
CSP-1 functions in biofilm development in the presence of hemoglobin is mostly independent of
the comDE pathway (Fig. 3.7B), suggesting the presence of a new signaling route for CSP-1 [139].

The CiaRH mutant exhibited a significant reduction in biofilm formation as well (Fig.
3.7A), and the addition of CSP-1 did not compensate for the loss of ciaRH, suggesting the two
systems likely operate independently of each other. The CiaRH TCS orchestrates the integrity
retention of the pneumococcal cell wall by preventing the lysis that is otherwise induced by stress,
antibiotic treatment, or competence development [140-143]. Interestingly, Spn senses free sialic
acid and upregulates ciaR in that sensing response. CiaR, in turn, indirectly regulates the activation
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of the nanAB genes, which respectively code for sialic acid cleavage (from the host
glycoconjugates) and uptake [144, 145]. Free sialic acid act as a signal for pneumococcal biofilms
in vitro and in vivo during colonization of the nasopharynx and lungs in a mouse carriage model
[61]. It is not clear, however, how CiaRH contributes to biofilm development in the presence of
hemoglobin. The significant biofilm formation exhibited by the comC and ciaRH mutants (Fig.
3.7A) demonstrates a redundancy in the pathways that orchestrate the biofilm response by
hemoglobin. We speculate that hemoglobin signaling of biofilms takes place from the
pneumococcal surface since hemoglobin is too big to diffuse through the cell wall and enter the
cell. A surface receptor and/or a hemoglobin-dependent heme importer might be needed to rely on
the signal, which leads to activation of the ciaRH and the comCDE genes. CSP-1 generation then
promotes signaling via unknown regulatory protein.

To our knowledge, this study is the first to present a biofilm induction by hemoglobin in
the genus Streptococcus. Other streptococci of the oral cavity share orthologs of the com and cia
system speculating if hemoglobin biofilm is a phenomenon found in these systems [146-149].
Recently, a study has reported that hemoglobin also induces biofilms in Staphylococcus aureus,
and increased colonization was observed in patients with frequent nose bleeds [150]. Collectively,
the observation of hemoglobin biofilm induction may help bridge the gap of understanding the
biofilm lifecycle of pneumococcus and other biofilm bacteria in vivo.
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Figure 3.1: Myoglobin and serum promotes pneumococcal growth in iron deplete and iron
complete THYB.

THYB was inoculated with D39 cells grown on BAPs (18 h, starting O.D.600 = 0.05).
Shown is growth in (A) THYB with 3mM di-pyridyl (DP), THYB with DP and 2 mM of FeNO3
(Fe), 10 µM Heme (Hm), 10% human serum (serum), 20 µM equine myoglobin (Mb), or 20 µM
hemoglobin (Hb); (B) THYB, THYB supplemented 2 mM of FeNO3 (Fe), 10 µM Heme (Hm),
10% human serum (serum), 20 µM equine myoglobin (Mb), or 20 µM hemoglobin (Hb). The data
are representative of three independent experiments performed in triplicates; error bars indicate
SD.

57

Figure 3.2: Hemoglobin enhances pneumococcal biofilm formation.
THYB was inoculated with Spn cells grown on BAPs (18 h, starting O.D.600 = 0.05).
Cultures were allowed to grow in microtiter plates, biofilm was quantified (18 h). Shown is D39
grown in (A) THYB, THYB with 80µM FeNO3 (Fe), 10 µM Heme (Hm), 20 µM equine myoglobin
(Mb), 10% human serum (serum), 20 µM BSA (BSA), or 0.5 to 20 µM hemoglobin (Hb); (B)
THYB with 3mM DP (DP), THYB with DP and 2mM FeNO3 (Fe), 20 µM BSA (BSA), 10 µM
Heme (Hm), 20 µM equine myoglobin (Mb), 10% human serum (serum), 20 µM BSA (BSA), or
0.5-20 µM hemoglobin (Hb); and (C) THYB with 20 µM denatured hemoglobin, filtered
hemoglobin, or the flow-through after hemoglobin filtration. (D) Growth of TIGR4 and the clinical
isolates 8655 and 3875 in THYB with 20 µM Hb. Insert shows crystal violet staining following
growth in THYB with or without hemoglobin (18 hours). The data are expressed as the mean 
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SD of at least two independent experiments each done in triplicates. The asterisks denote
statistically significant difference, P ≤ 0.05 (THYB-Hb vs. THYB in A-D, Student’s t-test).

Figure 3.3: Hemoglobin induces early and robust biofilm structures.

THYB with 20 M hemoglobin (Hb) was inoculated with D39 grown on BAPs (18 h,
starting O.D.600 = 0.05). (A) Cultures were allowed to grow in microtiter plates, biofilm and
biomass were quantified different time points. The data are expressed as the mean  SD of at
least two independent experiments each done in triplicates. The asterisks denote statistically
significant difference, P ≤ 0.05 (THYB-Hb vs. THYB, Student’s t-test). Confocal micrographs of
biofilms produced by GFP-expressing D39 [81] grown in 8-well glass wells in (B) THYB or in
(C) THYB with 20 µM hemoglobin. The DNA stained with TO-PRO-3 (green) and the capsule
with Alexa Fluor 555-labeled anti-serotype specific antibodies (red).
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Figure 3.4: Blood cells activates biofilm formation in a ply-dependent manner.

THYB was inoculated with Spn cells grown on BAPs (18 h, starting O.D.600 = 0.05).
Cultures were allowed to grow in microtiter plates. Shown is biofilm formation (18 hours) by (A)
D39 and TIGR4 grown in THYB or THYB supplemented with 0.1 - 0.5 % (v/v) washed blood
cells; (B) ply mutants in D39 and TIGR4 (filled) background grown in THYB, THYB and 0.3%
washed human blood cells (blood), or 20 µM hemoglobin (Hb). The data are expressed as the mean
 SD of at least two independent experiments each done in triplicates. The asterisks denote
statistical significance, P ≤ 0.05 (THYB vs. THYB-blood, in A and THYB-blood vs. THYB-Hb in
B, Student’s t-test).
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Figure 3.5: Spn transition from planktonic to biofilm growth in the presence of hemoglobin
involves transcriptome remodeling.

Venn diagram (using R) of differentially expressed genes in hemoglobin biofilm cells
compared to hemoglobin planktonic cells (fold change ≥ 2). (A) Genes upregulated; (B) Genes
downregulated.
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Figure 3.6: Differential gene expression in Spn grown in early biofilm.
The relative expression of selected genes in biofilms vs. planktonic cells (both with
hemoglobin) at 1 h and 2 h post hemoglobin addition (Y-axis) is plotted for D39 genes (X-axis).
(A) up-regulated genes. (B) down-regulated genes.
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Figure 3.7: Hemoglobin signaling of biofilms involves the comC and ciaRH genes.
THYB was inoculated with Spn cells grown on BAPs (18 h, starting O.D.600 = 0.05).
Cultures were allowed to grow in microtiter plates; biofilm was quantified (18 h). Shown is biofilm
biomass produced by D39 and isogenic mutants were grown in (A) THYB or THYB with 20 M
hemoglobin (Hb); and (B) in THYB with Hb and CSP1 (200 ng). The data are expressed as the
mean  SD of at least two independent experiments each done in triplicates. The asterisks denote
statistical significance, P ≤ 0.05 (wild-type vs. mutant in the presence of Hb or Hb+CSP1, Student’s
t-test).
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Table 3.1: Strains and plasmids used in this study.

Strains

description

Source or
references

Avery strain, clinical isolate, WT (capsular serotype
2), CSP1
GFP-expressing strain, D39/pMV158GFP Tetr

[112], [113]

TIGR4

Invasive clinical isolate, WT (capsular serotype 4),
CSP2

[49]

8655
3875
∆ply (SPJV14)
∆ply (SPJV18)
∆luxS (SPJV05)
∆comC (SPJV10)
∆comD (SPJV31)
∆comE (SPJV32)
∆ciaRH (2F45)
∆yesMN (2F26)
∆vicK (2F22)
E. coli strains
One shot Top-10
Plasmids
pMV158GFP

Invasive isolate (serotype 6B), CSP2
Invasive isolate (serotype 6B), CSP1
D39-derivative ply null mutant, Eryr
TIGR4-derivative ply null mutant, Eryr
D39-derivative luxS-null mutant, Eryr
D39-derivative comC null mutant, Eryr
D39-derivative comD null mutant, Cmr
D39-derivative comE null mutant, Cmr
D39-derivative ciaRH null mutant, Eryr
D39-derivative yesMN null mutant, Eryr
D39-derivative vicK null mutant, Cmr

CDC
CDC
[151]

Cloning host containing pJRS233 or pDC123

This study

S. pneumoniae mobilizable plasmid containing the
green fluorescent protein gene
Temperature sensitive vector containing ermC, Eryr
Vector containing cat-194, Cmr
Seamless cloning vector pUC19 for ciaRH deletion,
Ampr
Seamless cloning vector pUC19 for yesMN deletion,
Ampr
Seamless cloning vector pUC19 for vicK deletion,
Ampr

[152]

S. pneumoniae
strains
D39
D39 (SPJV01)

pJRS233
pDC123
pAF105
pAF108
pAF106

[81]

[81]
[120]

This study
This study
This study

This study
This study
This study
This study
This study
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Table 3.2: Primers used in this study.

Target
pUC19-L

Primers
Sequence (5' to 3')
ZE 774- L TGATTCTCGGCATGCAAGCTTGGCGTAATCAT
ZE 775-R TAAGACTCGTACCGAGCTCGAATTCACTGGCC

Comments
ciaRH
cloning

5′- region of
ciaRH

ZE 776-L CTCGGTACGAGTCTTATCTGGTGGTTTCAGCT
ZE 777-R CACACGGTCATGAGAAACTCCTCCTTATTAAA

ciaRH
cloning

ermC

ZE 778-L TTCTCATGACCGTGTGCTCTACGACCAAAACT
ZE 779-R GCATTATCCCGTGGAATTCCCCCCTTAACTTA

ciaRH
cloning

3′- region of
ciaRH

ZE 780-L TTCCACGGGATAATGCCGTCAAGTATACTGAG
ZE 781-R TGCATGCCGAGAATCATGCCCGTAAGAAAATT

ciaRH
cloning

pUC19-L

ZE 798-L ATGTTTTGGGCATGCAAGCTTGGCGTAATCAT
ZE 799-R CTTGAGACGTACCGAGCTCGAATTCACTGGCC

yesMN
cloning

5′- region of
yesMN

ZE 800-L CTCGGTACGTCTCAAGCAACCTGATTTTCTAT
ZE 801-R CACACGGTATCATTTCGAACATAGAGGTCATC

yesMN
cloning

ermC

ZE 802-L GAAATGATACCGTGTGCTCTACGACCAAAACT
ZE 803-R TATTGACCCCGTGGAATTCCCCCCTTAACTTA

yesMN
cloning

3′- region of
yesMN

ZE 804-L TTCCACGGGGTCAATACCGTATGAATGAAAAT
ZE 805-R TGCATGCCCAAAACATAGCCAACGTAAGTATA

yesMN
cloning

pUC19-L

ZE 782-L AGAAAGAAGGCATGCAAGCTTGGCGTAATCAT
ZE 783-R CACAATAGGTACCGAGCTCGAATTCACTGGCC

VicK
cloning

5′- region of
vicK

ZE 784-L CTCGGTACCTATTGTGTCTTCTGACTATTTTT
ZE 785-R CATCGGTCTCAAGCATTATTTCTCATGTAATA

vicK
cloning

Cat-194

ZE 786-L ATGCTTGAGACCGATGATGAAGAAAAGAATTT
ZE 787-R TCACTCTTTTATAAAAGCCAGTCATTAGGCCT

vicK
cloning

3′- region of
vicK

ZE 788-L TTTTATAAAAGAGTGAATACGGCAAGGGTTCA
ZE789-R TGCATGCCTTCTTTCTATATCTCTGTCAATGG

vicK
cloning

65

Table 3.3: Biofilm cell counts.
*NS denotes THYB, Student t test statistical analysis, 6h (P=0.05), 8h (P=0.05)
Incubation time (h)

Conditions

Biofilm (CFU/ml)

NS

6.1 ± 1.94 X 107

Hb

2.2 ± 0.57 X 108

NS

4.27 ± 2.6 X 107

Hb

1.61 ± 0.41 X 108

6

8
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4

GENERAL DISCUSSION

Spn requires iron for growth and obtaining the metal from the host heme and hemoproteins
is crucial for the host persistence and establishment of infection. During infections, heme bound
to hemoglobin serves as a significant reserve for metal iron; yet substantial knowledge gaps exist
concerning the role of heme and hemoglobin as nutrients in Spn physiology and infection. This
dissertation addressed these important knowledge gaps and examined the role of hemoglobin as a
nutrient and described the part of this host protein in pneumococcal adaptation to the host
environment. The data showed that hemoglobin is a preferred iron source and suggest that heme
metabolism benefit Spn growth. The experiments demonstrated that hemoglobin promotes Spn
biofilms and has a dramatic impact on the bacterial transcriptome. These new observations and
their impact on the current understanding of Spn interactions with its human host are discussed
below.
The fermentative anaerobe, Spn, is quite fastidious and difficult to cultivate under
laboratory conditions. One of the main observations made in this study is that hemoglobin induces
a robust Spn growth in vitro and shapes Spn transcriptome (Chapter one). The hemoglobindependent growth stimulation is observed in both iron-deplete or complete medium independently
of the growth assay and is conserved in multiple strains. Spn typically exhibits limited growth in
batch cultures and enters early into the stationary phase. The reason for the limited growth Spn
exhibits in vitro is not fully understood. Acidification and other growth conditions were suggested
to limit cultivation. Controlling for these and other factors, however, did not improve Spn
cultivation uniformly [65, 105]. The data in Chapter one show that hemoglobin expands Spn
growth in a medium that was not otherwise replenished, without pH control, with or without precultivation. The possibility that the positive growth impact of hemoglobin results from an intrinsic
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peroxidase activity [88], and thus defense from hydrogen peroxide [89], was ruled out. Moreover,
the data show that hemoglobin in its native form provides Spn with growth advantage rather than
a nonspecific increase in peptides and amino acids availability, or the presence of low molecular
weight contaminants. Together, these observations raise the novel hypothesis that hemoglobin
redirects a regulatory mechanism(s) that otherwise leads to premature growth arrest during in vitro
cultivation by a novel mechanism. In addition to this novelty, the identification of hemoglobin as
a Spn growth factor has important implications, since methods to optimize and improve
pneumococcal growth are needed to achieve maximum biomass (and capsular production) for
vaccine preparations.

The role of iron hemostasis in hemoglobin growth promotion is somewhat puzzling.
Growth with hemoglobin did not lead to an elevated level of cellular iron, suggesting that
hemoglobin does not supply Spn with the iron it needs to reach its maximal growth potential.
Moreover, Spn cells grown in THYB supplemented with ferric iron imports less of the metal
compared to cells grown in THYB or THYB with hemoglobin. These observations support a new
premise that heme is more useful for the pathogen’s physiology then free iron, and therefore, by
donating heme, hemoglobin provides Spn with a highly beneficial growth nutrient. Mutant analysis
established the role of Spbhp-37 in the acquisition of iron from heme or hemoglobin. Inactivation
of spbhp-37 also impaired Spn growth even in standard THYB, suggesting that heme is the key
iron source for Spn in THYB. These findings provided additional support to the idea stated above
that heme is growth advantageous for Spn. The reduced growth of the mutant even in the presence
of hemoglobin in THYB compared to the wildtype suggest that this hemoglobin receptor mediate,
at least in part, the growth benefits of hemoglobin.
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Hemoglobin has a significant impact on Spn transcriptome. Most noteworthy changes in
this transcriptome shift included changes in the expression of metabolic and virulence genes with
an established role in colonization. Furthermore, hemoglobin induces the expression of genes
involved in the uptake and use of host-derived sugars found in the mucosa and extracellular matrix.
Together with in vitro growth experiments, the data show that the presence of hemoglobin is an
essential cue for Spn and implies that hemoglobin promotes pneumococcal adaptation to the
respiratory tract and mucosal surface. The proposal that hemoglobin served not only as an iron
source but also activates host adaptation is a novel concept in the area of host-pathogen
interactions, which merit additional inquiries into the mechanism involved.

Another significant finding of this project is the observation that hemoglobin induces early
and robust pneumococcal biofilm structures in vitro (Chapter two). Pneumococcal biofilms are
observed in vivo in multiple sites and different stages of infection, while the pathogen exhibits
only limited biofilm growth and structures in vitro. These perplexing characteristics of Spn suggest
that in vitro model systems are missing an essential element of true infection. Hence, the finding
that the simple addition of hemoglobin to the growth medium is sufficient to induce vigorous
biofilm growth is exciting and supports the hypothesis that the hemoglobin signals the host
environment to Spn.

The addition of hemoglobin to THYB, either as the sole iron source or as a supplement,
triggered a dose-depended biofilm formation in several encapsulated strains, including vaccine
serotypes. This biofilm response is dependent on hemoglobin and is not seen with other host
proteins, heme or iron, but was conserved in multiple serotypes. While the addition of myoglobin
and serum promotes more robust pneumococcal growth, these host heme sources did not induce

69
biofilms. These observations provide new insights into the pneumococcal response to hemoglobin;
First, if growth promotion is associated with host heme sources and not just with hemoglobin, it
suggests that it’s the heme in hemoglobin, myoglobin, and serum benefits Spn physiology. Free
heme does not have this effect, likely due to toxicity. Furthermore, the finding that only
hemoglobin promotes biofilm development indicates that separate mechanisms mediate the growth
and biofilm response to hemoglobin in Spn. Ex-vivo experiments showed that washed blood cells
supported biofilms in a Ply dependent manner. These observations suggest that Ply releases the
hemoglobin from the erythrocytes, which in turn activates biofilms. These data also imply that the
biofilm response to hemoglobin can take place in vivo when Spn encounters blood.

Transcriptome analysis shows that Spn transitioning into biofilms with hemoglobin exhibit
a widespread shift, activating genes that are expressed in vivo during biofilm growth [124, 153].
These studies revealed the induction of several two-component regulatory systems in early
biofilms cells. The mutant analysis led to the conclusion that the pneumococcal biofilm response
to hemoglobin is mediated by a new mechanism (see proposed biofilm model) that involves the
comC and ciaRH genes. While the findings are consistent with the part in biofilm development
reported for both the comCDE and ciaRH systems [124-126, 128], the discoveries also expose the
existence of a new regulatory element(s). Specifically, inactivation of comC resulted in the most
significant loss of biofilm formation in Spn grown with hemoglobin, while the loss of comD or
comE had only limited influence. Therefore, for biofilm development in the presence of
hemoglobin, CSP-1 functions mostly independent of the comDE pathway [139]. The biofilm
formation still exhibited by the comC and the ciaRH mutants show that there is a redundancy in
the channels that orchestrate the biofilm response by hemoglobin. We speculate that hemoglobin
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signaling of biofilms takes place from the pneumococcal surface since hemoglobin is too big to
diffuse through the cell wall and enter the cell. A surface receptor and or a hemoglobin-dependent
heme importer are likely to be needed to rely on the signal that leads to activation of the ciaRH
and the comCDE genes (see proposed biofilm model).

Biofilms play a crucial role in pneumococcal establishment in the nasopharynx, ears, lungs,
and heart in vivo. However, the biofilm regulatory network has not been entirely elucidated. The
new observation of Spn biofilm induction by hemoglobin promotes the current understanding of
the biofilm lifecycle in Spn and possibly other biofilm bacteria. More work is needed to identify
the signaling partner(s) for CSP-1 to activate biofilms in the presence of hemoglobin and the
mechanism that mediates the part of CiaRH.

In summary, this dissertation informs current paradigms in pneumococcal physiology and
virulence. It expands the role of hemoglobin from a nutrient into a key player in Spn interactions
with its human host.
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Figure 3.8: Proposed model for biofilm induction by hemoglobin.

Hemoglobin generates a signal by binding to a surface receptor or an associated transporter,
triggering signaling cascades that activate ciaRH and the comCDE genes. The generated CSP-1 is
exported and activated an unknown TCS that mediates biofilm formation.

Disclaimer: I, Fahmina Akhter, conceived and contributed to the design and implementation of
the research for the two chapters presented in this dissertation. I received some strains as a
generous gift from Dr. Jorge E Vidal that I used in some experiments in both chapter one and
chapter two. With consultation with Dr. Zehava Eichenbaum, I wrote two manuscripts based on
the findings in chapter one and chapter two. Other co-authors in the manuscripts contributed to
some of the experiments. I conducted the RNA-Seq experiments with the help of Dr. Yoann Le
Breton, and Dr. Kevin S. McIver using the sequencing facility at the University of Maryland,
College Park. I performed the RNA-Seq data analyses with the help of Dr. Shrikant Pawar. Edroyal
Womack contributed to some of the mutant construction and growth assay.

72
REFERENCES
1.

Kadioglu, A., et al., The role of Streptococcus pneumoniae virulence factors in host
respiratory colonization and disease. Nat Rev Microbiol, 2008. 6(4): p. 288-301.

2.

Adegbola, R.A., et al., Carriage of Streptococcus pneumoniae and other respiratory
bacterial pathogens in low and lower-middle income countries: a systematic review and
meta-analysis. PLoS One, 2014. 9(8): p. e103293.

3.

Chao, Y., et al., Streptococcus pneumoniae biofilm formation and dispersion during
colonization and disease. Front Cell Infect Microbiol, 2014. 4: p. 194.

4.

Korona-Glowniak, I. and A. Malm, Characteristics of Streptococcus pneumoniae strains
colonizing upper respiratory tract of healthy preschool children in Poland.
ScientificWorldJournal, 2012. 2012: p. 732901.

5.

Klugman, K.P., S.A. Madhi, and W.C. Albrich, Novel approaches to the identification of
Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect
Dis, 2008. 47 Suppl 3: p. S202-6.

6.

van der Poll, T. and S.M. Opal, Pathogenesis, treatment, and prevention of pneumococcal
pneumonia. Lancet, 2009. 374(9700): p. 1543-56.

7.

Levine, O.S. and K.P. Klugman, Editorial: Breathing new life into pneumonia
epidemiology. Am J Epidemiol, 2009. 170(9): p. 1067-8.

8.

Walker, C.L.F., et al., Global burden of childhood pneumonia and diarrhoea. Lancet,
2013. 381(9875): p. 1405-1416.

9.

Eurich, D.T., et al., Risk of heart failure after community acquired pneumonia: prospective
controlled study with 10 years of follow-up. BMJ, 2017. 356: p. j413.

73
10.

Musher, D.M., et al., The association between pneumococcal pneumonia and acute cardiac
events. Clin Infect Dis, 2007. 45(2): p. 158-65.

11.

Jedrzejas, M.J., Pneumococcal virulence factors: structure and function. Microbiol Mol
Biol Rev, 2001. 65(2): p. 187-207 ; first page, table of contents.

12.

Davis, B.M., et al., Influenza and community-acquired pneumonia interactions: the impact
of order and time of infection on population patterns. Am J Epidemiol, 2012. 175(5): p.
363-7.

13.

Klein, E.Y., et al., The frequency of influenza and bacterial coinfection: a systematic
review and meta-analysis. Influenza Other Respir Viruses, 2016. 10(5): p. 394-403.

14.

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of
lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the
Global Burden of Disease Study 2016. Lancet Infect Dis, 2018. 18(11): p. 1191-1210.

15.

Brooks, L.R.K. and G.I. Mias, Streptococcus pneumoniae's Virulence and Host Immunity:
Aging, Diagnostics, and Prevention. Front Immunol, 2018. 9: p. 1366.

16.

Gamez, G., et al., The variome of pneumococcal virulence factors and regulators. BMC
Genomics, 2018. 19(1): p. 10.

17.

Weiser, J.N., D.M. Ferreira, and J.C. Paton, Streptococcus pneumoniae: transmission,
colonization and invasion. Nat Rev Microbiol, 2018. 16(6): p. 355-367.

18.

Philips, B.J., et al., Factors determining the appearance of glucose in upper and lower
respiratory tract secretions. Intensive Care Med, 2003. 29(12): p. 2204-2210.

19.

Shelburne, S.A., et al., The role of complex carbohydrate catabolism in the pathogenesis
of invasive streptococci. Trends Microbiol, 2008. 16(7): p. 318-25.

74
20.

Rose, M.C. and J.A. Voynow, Respiratory tract mucin genes and mucin glycoproteins in
health and disease. Physiol Rev, 2006. 86(1): p. 245-78.

21.

Yesilkaya, H., et al., The ability to utilize mucin affects the regulation of virulence gene
expression in Streptococcus pneumoniae. FEMS Microbiol Lett, 2008. 278(2): p. 231-5.

22.

Burnaugh, A.M., L.J. Frantz, and S.J. King, Growth of Streptococcus pneumoniae on
human glycoconjugates is dependent upon the sequential activity of bacterial
exoglycosidases. J Bacteriol, 2008. 190(1): p. 221-30.

23.

Terra, V.S., et al., Characterization of novel beta-galactosidase activity that contributes to
glycoprotein degradation and virulence in Streptococcus pneumoniae. Infect Immun,
2010. 78(1): p. 348-57.

24.

Gosink, K.K., et al., Role of novel choline binding proteins in virulence of Streptococcus
pneumoniae. Infect Immun, 2000. 68(10): p. 5690-5.

25.

Bergmann, S. and S. Hammerschmidt, Versatility of pneumococcal surface proteins.
Microbiology, 2006. 152(Pt 2): p. 295-303.

26.

Hartel, T., et al., Impact of glutamine transporters on pneumococcal fitness under
infection-related conditions. Infect Immun, 2011. 79(1): p. 44-58.

27.

JS, D.C.a.B., Streptococcus pneumoniae lipoproteins and ABC transporters. In
Streptococcus pneumoniae: Molecular Mechanisms of Host-Pathogen Interactions (Brown
JS, Hammerschmidt S and Orihuela C, eds). 2015: p. pp. 347–362.

28.

Kerr, A.R., et al., The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved
in nasopharyngeal colonization but not in invasive disease. Infect Immun, 2004. 72(7): p.
3902-6.

75
29.

Kohler, S., et al., Pneumococcal lipoproteins involved in bacterial fitness, virulence, and
immune evasion. FEBS Lett, 2016. 590(21): p. 3820-3839.

30.

Ogunniyi, A.D., et al., Identification of genes that contribute to the pathogenesis of invasive
pneumococcal disease by in vivo transcriptomic analysis. Infect Immun, 2012. 80(9): p.
3268-78.

31.

Pribyl, T., et al., Influence of impaired lipoprotein biogenesis on surface and exoproteome
of Streptococcus pneumoniae. J Proteome Res, 2014. 13(2): p. 650-67.

32.

Miethke, M., Molecular strategies of microbial iron assimilation: from high-affinity
complexes to cofactor assembly systems. Metallomics, 2013. 5(1): p. 15-28.

33.

Skaar, E.P., The battle for iron between bacterial pathogens and their vertebrate hosts.
PLoS Pathog, 2010. 6(8): p. e1000949.

34.

Bullen, J.J., et al., Natural resistance, iron and infection: a challenge for clinical medicine.
J Med Microbiol, 2006. 55(Pt 3): p. 251-258.

35.

Tong, Y. and M. Guo, Bacterial heme-transport proteins and their heme-coordination
modes. Arch Biochem Biophys, 2009. 481(1): p. 1-15.

36.

Chiabrando, D., et al., Heme in pathophysiology: a matter of scavenging, metabolism and
trafficking across cell membranes. Front Pharmacol, 2014. 5: p. 61.

37.

Maines, M.D. and A. Kappas, The degradative effects of porphyrins and heme compounds
on components of the microsomal mixed function oxidase system. J Biol Chem, 1975.
250(6): p. 2363-9.

38.

Solar, I., J. Dulitzky, and N. Shaklai, Hemin-promoted peroxidation of red cell cytoskeletal
proteins. Arch Biochem Biophys, 1990. 283(1): p. 81-9.

76
39.

Brown, J.S. and D.W. Holden, Iron acquisition by Gram-positive bacterial pathogens.
Microbes Infect, 2002. 4(11): p. 1149-56.

40.

Nobles, C.L. and A.W. Maresso, The theft of host heme by Gram-positive pathogenic
bacteria. Metallomics, 2011. 3(8): p. 788-96.

41.

Johnson, E.E. and M. Wessling-Resnick, Iron metabolism and the innate immune response
to infection. Microbes Infect, 2012. 14(3): p. 207-16.

42.

Beutler, E. and J. Waalen, The definition of anemia: what is the lower limit of normal of
the blood hemoglobin concentration? Blood, 2006. 107(5): p. 1747-50.

43.

Tai, S.S., C.J. Lee, and R.E. Winter, Hemin utilization is related to virulence of
Streptococcus pneumoniae. Infect Immun, 1993. 61(12): p. 5401-5.

44.

Brown, J.S., S.M. Gilliland, and D.W. Holden, A Streptococcus pneumoniae pathogenicity
island encoding an ABC transporter involved in iron uptake and virulence. Mol Microbiol,
2001. 40(3): p. 572-85.

45.

Brown, J.S., et al., Characterization of pit, a Streptococcus pneumoniae iron uptake ABC
transporter. Infect Immun, 2002. 70(8): p. 4389-98.

46.

Cao, K., et al., Evolution and molecular mechanism of PitAs in iron transport of
Streptococcus species. J Inorg Biochem, 2018. 182: p. 113-123.

47.

Tai, S.S., C. Yu, and J.K. Lee, A solute binding protein of Streptococcus pneumoniae iron
transport. FEMS Microbiol Lett, 2003. 220(2): p. 303-8.

48.

Cheng, W., et al., Structures of Streptococcus pneumoniae PiaA and its complex with
ferrichrome reveal insights into the substrate binding and release of high affinity iron
transporters. PLoS One, 2013. 8(8): p. e71451.

77
49.

Tettelin, H., et al., Complete genome sequence of a virulent isolate of Streptococcus
pneumoniae. Science, 2001. 293(5529): p. 498-506.

50.

Yang, X.Y., et al., Integrated Translatomics with Proteomics to Identify Novel IronTransporting Proteins in Streptococcus pneumoniae. Front Microbiol, 2016. 7: p. 78.

51.

Yang, X.Y., et al., Lipoprotein SPD_1609 of Streptococcus pneumoniae Promotes
Adherence and Invasion to Epithelial Cells Contributing to Bacterial Virulence. Front
Microbiol, 2019. 10: p. 1769.

52.

Romero-Espejel, M.E., et al., Characterization of Spbhp-37, a Hemoglobin-Binding
Protein of Streptococcus pneumoniae. Front Cell Infect Microbiol, 2016. 6: p. 47.

53.

Miao, X., et al., A Novel Iron Transporter SPD_1590 in Streptococcus pneumoniae
Contributing to Bacterial Virulence Properties. Front Microbiol, 2018. 9: p. 1624.

54.

Domenech, M., E. Garcia, and M. Moscoso, Biofilm formation in Streptococcus
pneumoniae. Microb Biotechnol, 2012. 5(4): p. 455-65.

55.

Hall-Stoodley, L., et al., Direct detection of bacterial biofilms on the middle-ear mucosa
of children with chronic otitis media. Jama, 2006. 296(2): p. 202-11.

56.

Sanderson, A.R., J.G. Leid, and D. Hunsaker, Bacterial biofilms on the sinus mucosa of
human subjects with chronic rhinosinusitis. Laryngoscope, 2006. 116(7): p. 1121-6.

57.

Shenoy, A.T., et al., Streptococcus pneumoniae in the heart subvert the host response
through biofilm-mediated resident macrophage killing. PLoS Pathog, 2017. 13(8): p.
e1006582.

58.

Shak, J.R., J.E. Vidal, and K.P. Klugman, Influence of bacterial interactions on
pneumococcal colonization of the nasopharynx. Trends Microbiol, 2013. 21(3): p. 129-35.

78
59.

Lattar, S.M., et al., A Mechanism of Unidirectional Transformation, Leading to Antibiotic
Resistance, Occurs within Nasopharyngeal Pneumococcal Biofilm Consortia. MBio, 2018.
9(3).

60.

Pettigrew, M.M., et al., Dynamic changes in the Streptococcus pneumoniae transcriptome
during transition from biofilm formation to invasive disease upon influenza A virus
infection. Infect Immun, 2014. 82(11): p. 4607-19.

61.

Trappetti, C., et al., Sialic acid: a preventable signal for pneumococcal biofilm formation,
colonization, and invasion of the host. J Infect Dis, 2009. 199(10): p. 1497-505.

62.

Blanchette, K.A., et al., Neuraminidase A-Exposed Galactose Promotes Streptococcus
pneumoniae Biofilm Formation during Colonization. Infect Immun, 2016. 84(10): p. 292232.

63.

Rose, L., et al., Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block
adhesion and protect mice against pneumococcal challenge. J Infect Dis, 2008. 198(3): p.
375-83.

64.

Sanchez, C.J., et al., The pneumococcal serine-rich repeat protein is an intra-species
bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS
Pathog, 2010. 6(8): p. e1001044.

65.

Carvalho, S.M., O.P. Kuipers, and A.R. Neves, Environmental and nutritional factors that
affect growth and metabolism of the pneumococcal serotype 2 strain D39 and its
nonencapsulated derivative strain R6. PLoS One, 2013. 8(3): p. e58492.

66.

Goncalves, V.M., et al., Purification of capsular polysaccharide from Streptococcus
pneumoniae serotype 23F by a procedure suitable for scale-up. Biotechnol Appl Biochem,
2003. 37(Pt 3): p. 283-7.

79
67.

Massaldi, H., et al., Features of bacterial growth and polysaccharide production of
Streptococcus pneumoniae serotype 14. Biotechnol Appl Biochem, 2010. 55(1): p. 37-43.

68.

Slotved, H.C. and C. Satzke, In vitro growth of pneumococcal isolates representing 23
different serotypes. BMC Res Notes, 2013. 6: p. 208.

69.

Berry, A.M., et al., Contribution of autolysin to virulence of Streptococcus pneumoniae.
Infect Immun, 1989. 57(8): p. 2324-30.

70.

Berry, A.M. and J.C. Paton, Additive attenuation of virulence of Streptococcus pneumoniae
by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence
proteins. Infect Immun, 2000. 68(1): p. 133-40.

71.

Regev-Yochay, G., et al., SpxB is a suicide gene of Streptococcus pneumoniae and confers
a selective advantage in an in vivo competitive colonization model. J Bacteriol, 2007.
189(18): p. 6532-9.

72.

Grousd, J.A., H.E. Rich, and J.F. Alcorn, Host-Pathogen Interactions in Gram-Positive
Bacterial Pneumonia. Clin Microbiol Rev, 2019. 32(3).

73.

Lopez, C.A. and E.P. Skaar, The Impact of Dietary Transition Metals on Host-Bacterial
Interactions. Cell Host Microbe, 2018. 23(6): p. 737-748.

74.

Palmer, L.D. and E.P. Skaar, Transition Metals and Virulence in Bacteria. Annu Rev
Genet, 2016. 50: p. 67-91.

75.

Turner, A.G., et al., Transition Metal Homeostasis in Streptococcus pyogenes and
Streptococcus pneumoniae. Adv Microb Physiol, 2017. 70: p. 123-191.

76.

Ge, R. and X. Sun, Iron acquisition and regulation systems in Streptococcus species.
Metallomics, 2014. 6(5): p. 996-1003.

80
77.

O'Brien, K.L., et al., Evaluation of a medium (STGG) for transport and optimal recovery
of Streptococcus pneumoniae from nasopharyngeal secretions collected during field
studies. J Clin Microbiol, 2001. 39(3): p. 1021-4.

78.

Porter, R.D. and W.R. Guild, Characterization of some pneumococcal bacteriophages. J
Virol, 1976. 19(2): p. 659-67.

79.

EPA, U.S., Method 200.8: Determination of Trace Elements in Waters and Wastes by
Inductively Coupled Plasma-Mass Spectrometry. 1994.

80.

EPA, U.S., Method 3052: Microwave Assisted Acid Digestion of Siliceous and Organically
Based Matrices. 1996. Revision 0.

81.

Vidal, J.E., et al., The LuxS-dependent quorum-sensing system regulates early biofilm
formation by Streptococcus pneumoniae strain D39. Infect Immun, 2011. 79(10): p. 405060.

82.

Havarstein, L.S., G. Coomaraswamy, and D.A. Morrison, An unmodified heptadecapeptide
pheromone induces competence for genetic transformation in Streptococcus pneumoniae.
Proc Natl Acad Sci U S A, 1995. 92(24): p. 11140-4.

83.

Langmead, B., et al., Ultrafast and memory-efficient alignment of short DNA sequences to
the human genome. Genome Biol, 2009. 10(3): p. R25.

84.

Liao, Y., G.K. Smyth, and W. Shi, featureCounts: an efficient general purpose program
for assigning sequence reads to genomic features. Bioinformatics, 2014. 30(7): p. 923-30.

85.

Love, M.I., W. Huber, and S. Anders, Moderated estimation of fold change and dispersion
for RNA-seq data with DESeq2. Genome Biol, 2014. 15(12): p. 550.

81
86.

Cook, L.C.C., et al., Transcriptomic Analysis of Streptococcus pyogenes Colonizing the
Vaginal Mucosa Identifies hupY, an MtsR-Regulated Adhesin Involved in Heme
Utilization. mBio, 2019. 10(3).

87.

Ponka, P., et al., The effect of various chelating agents on the mobilization of iron from
reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone. Biochim
Biophys Acta, 1984. 802(3): p. 477-89.

88.

King, K.Y., J.A. Horenstein, and M.G. Caparon, Aerotolerance and peroxide resistance in
peroxidase and PerR mutants of Streptococcus pyogenes. J Bacteriol, 2000. 182(19): p.
5290-9.

89.

Bates, C.S., et al., Identification and characterization of a Streptococcus pyogenes operon
involved in binding of hemoproteins and acquisition of iron. Infect Immun, 2003. 71(3): p.
1042-55.

90.

Bai, X.H., et al., Structure of pneumococcal peptidoglycan hydrolase LytB reveals insights
into the bacterial cell wall remodeling and pathogenesis. J Biol Chem, 2014. 289(34): p.
23403-16.

91.

Eijkelkamp, B.A., et al., The First Histidine Triad Motif of PhtD Is Critical for Zinc
Homeostasis in Streptococcus pneumoniae. Infect Immun, 2016. 84(2): p. 407-15.

92.

Jensch, I., et al., PavB is a surface-exposed adhesin of Streptococcus pneumoniae
contributing to nasopharyngeal colonization and airways infections. Mol Microbiol, 2010.
77(1): p. 22-43.

93.

Romero-Espejel, M.E., M.A. Gonzalez-Lopez, and J. Olivares-Trejo Jde, Streptococcus
pneumoniae requires iron for its viability and expresses two membrane proteins that bind
haemoglobin and haem. Metallomics, 2013. 5(4): p. 384-9.

82
94.

Shafeeq, S., O.P. Kuipers, and T.G. Kloosterman, Cellobiose-mediated gene expression in
Streptococcus pneumoniae: a repressor function of the novel GntR-type regulator BguR.
PLoS One, 2013. 8(2): p. e57586.

95.

Bidossi, A., et al., A functional genomics approach to establish the complement of
carbohydrate transporters in Streptococcus pneumoniae. PLoS One, 2012. 7(3): p.
e33320.

96.

Dehal, P.S., et al., MicrobesOnline: an integrated portal for comparative and functional
genomics. Nucleic Acids Res, 2010. 38(Database issue): p. D396-400.

97.

Anzaldi, L.L. and E.P. Skaar, Overcoming the heme paradox: heme toxicity and tolerance
in bacterial pathogens. Infect Immun, 2010. 78(12): p. 4977-89.

98.

Sachla, A.J., et al., The crimson conundrum: heme toxicity and tolerance in GAS. Front
Cell Infect Microbiol, 2014. 4: p. 159.

99.

Sheldon, J.R. and D.E. Heinrichs, Recent developments in understanding the iron
acquisition strategies of gram positive pathogens. FEMS Microbiol Rev, 2015. 39(4): p.
592-630.

100.

Montanez, G.E., M.N. Neely, and Z. Eichenbaum, The streptococcal iron uptake (Siu)
transporter is required for iron uptake and virulence in a zebrafish infection model.
Microbiology, 2005. 151(Pt 11): p. 3749-3757.

101.

Rouault, T.A., Microbiology. Pathogenic bacteria prefer heme. Science, 2004. 305(5690):
p. 1577-8.

102.

Lyles, K.V. and Z. Eichenbaum, From Host Heme To Iron: The Expanding Spectrum of
Heme Degrading Enzymes Used by Pathogenic Bacteria. Front Cell Infect Microbiol,
2018. 8: p. 198.

83
103.

Foresti, R., C.J. Green, and R. Motterlini, Generation of bile pigments by haem oxygenase:
a refined cellular strategy in response to stressful insults. Biochem Soc Symp, 2004(71):
p. 177-92.

104.

Vitek, L. and H.A. Schwertner, The heme catabolic pathway and its protective effects on
oxidative stress-mediated diseases. Adv Clin Chem, 2007. 43: p. 1-57.

105.

Mercade, M., N.D. Lindley, and P. Loubiere, Metabolism of Lactococcus lactis subsp.
cremoris MG 1363 in acid stress conditions. Int J Food Microbiol, 2000. 55(1-3): p. 1615.

106.

Claverys, J.P., B. Grossiord, and G. Alloing, Is the Ami-AliA/B oligopeptide permease of
Streptococcus pneumoniae involved in sensing environmental conditions? Res Microbiol,
2000. 151(6): p. 457-63.

107.

Cundell, D.R., et al., Peptide permeases from Streptococcus pneumoniae affect adherence
to eucaryotic cells. Infect Immun, 1995. 63(7): p. 2493-8.

108.

Piet, J.R., et al., Streptococcus pneumoniae arginine synthesis genes promote growth and
virulence in pneumococcal meningitis. J Infect Dis, 2014. 209(11): p. 1781-91.

109.

Paixao, L., et al., Host glycan sugar-specific pathways in Streptococcus pneumoniae:
galactose as a key sugar in colonisation and infection [corrected]. PLoS One, 2015. 10(3):
p. e0121042.

110.

Minhas, V., et al., Capacity To Utilize Raffinose Dictates Pneumococcal Disease
Phenotype. MBio, 2019. 10(1).

111.

CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S.
Department of Health and Human Services, CDC; 2019. 2019.

84
112.

Avery, O.T., C.M. Macleod, and M. McCarty, Studies on the Chemical Nature of the
Substance Inducing Transformation of Pneumococcal Types : Induction of Transformation
by a Desoxyribonucleic Acid Fraction Isolated from Pneumococcus Type Iii. J Exp Med,
1944. 79(2): p. 137-58.

113.

Lanie, J.A., et al., Genome sequence of Avery's virulent serotype 2 strain D39 of
Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain
R6. J Bacteriol, 2007. 189(1): p. 38-51.

114.

Chenoweth, C.E., et al., Antimicrobial resistance in Streptococcus pneumoniae:
implications for patients with community-acquired pneumonia. Mayo Clin Proc, 2000.
75(11): p. 1161-8.

115.

Kim, L., et al., Biological and Epidemiological Features of Antibiotic-Resistant
Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States
Perspective. Clin Microbiol Rev, 2016. 29(3): p. 525-52.

116.

Budhani, R.K. and J.K. Struthers, The use of Sorbarod biofilms to study the antimicrobial
susceptibility of a strain of Streptococcus pneumoniae. J Antimicrob Chemother, 1997.
40(4): p. 601-2.

117.

Donlan, R.M., et al., Model system for growing and quantifying Streptococcus pneumoniae
biofilms in situ and in real time. Appl Environ Microbiol, 2004. 70(8): p. 4980-8.

118.

Marks, L.R., G.I. Parameswaran, and A.P. Hakansson, Pneumococcal interactions with
epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in
vivo. Infect Immun, 2012. 80(8): p. 2744-60.

119.

Parker, D., et al., The NanA neuraminidase of Streptococcus pneumoniae is involved in
biofilm formation. Infect Immun, 2009. 77(9): p. 3722-30.

85
120.

Vidal, J.E., et al., Quorum-sensing systems LuxS/autoinducer 2 and Com regulate
Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human
respiratory cells. Infect Immun, 2013. 81(4): p. 1341-53.

121.

Trappetti, C., et al., Extracellular matrix formation enhances the ability of Streptococcus
pneumoniae to cause invasive disease. PLoS One, 2011. 6(5): p. e19844.

122.

Weimer, K.E., et al., Coinfection with Haemophilus influenzae promotes pneumococcal
biofilm formation during experimental otitis media and impedes the progression of
pneumococcal disease. J Infect Dis, 2010. 202(7): p. 1068-75.

123.

Moscoso, M., E. Garcia, and R. Lopez, Biofilm formation by Streptococcus pneumoniae:
role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J
Bacteriol, 2006. 188(22): p. 7785-95.

124.

Oggioni, M.R., et al., Switch from planktonic to sessile life: a major event in pneumococcal
pathogenesis. Mol Microbiol, 2006. 61(5): p. 1196-210.

125.

Munoz-Elias, E.J., J. Marcano, and A. Camilli, Isolation of Streptococcus pneumoniae
biofilm mutants and their characterization during nasopharyngeal colonization. Infect
Immun, 2008. 76(11): p. 5049-61.

126.

Blanchette-Cain, K., et al., Streptococcus pneumoniae biofilm formation is strain
dependent, multifactorial, and associated with reduced invasiveness and immunoreactivity
during colonization. MBio, 2013. 4(5): p. e00745-13.

127.

Mayanskiy,

A.N.,

et

al.,

[BIOFILM

FORMATION

BY

PNEUMONIAE]. Mol Gen Mikrobiol Virusol, 2015. 33(3): p. 16-22.

STREPTOCOCCUS

86
128.

Trappetti, C., et al., The impact of the competence quorum sensing system on Streptococcus
pneumoniae biofilms varies depending on the experimental model. BMC Microbiol, 2011.
11: p. 75.

129.

Berry, A.M., et al., Effect of defined point mutations in the pneumolysin gene on the
virulence of Streptococcus pneumoniae. Infect Immun, 1995. 63(5): p. 1969-74.

130.

Bokori-Brown, M., et al., Red Blood Cell Susceptibility to Pneumolysin: CORRELATION
WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES. J Biol Chem, 2016.
291(19): p. 10210-27.

131.

Shewell, L.K., et al., The cholesterol-dependent cytolysins pneumolysin and streptolysin O
require binding to red blood cell glycans for hemolytic activity. Proc Natl Acad Sci U S A,
2014. 111(49): p. E5312-20.

132.

Allan, R.N., et al., Pronounced metabolic changes in adaptation to biofilm growth by
Streptococcus pneumoniae. PLoS One, 2014. 9(9): p. e107015.

133.

Embry, A., E. Hinojosa, and C.J. Orihuela, Regions of Diversity 8, 9 and 13 contribute to
Streptococcus pneumoniae virulence. BMC Microbiol, 2007. 7: p. 80.

134.

Hoover, S.E., et al., A new quorum-sensing system (TprA/PhrA) for Streptococcus
pneumoniae D39 that regulates a lantibiotic biosynthesis gene cluster. Mol Microbiol,
2015. 97(2): p. 229-43.

135.

Sanchez, C.J., et al., Streptococcus pneumoniae in biofilms are unable to cause invasive
disease due to altered virulence determinant production. PLoS One, 2011. 6(12): p.
e28738.

136.

Trappetti, C., et al., LuxS mediates iron-dependent biofilm formation, competence, and
fratricide in Streptococcus pneumoniae. Infect Immun, 2011. 79(11): p. 4550-8.

87
137.

Bortoni, M.E., et al., The pneumococcal response to oxidative stress includes a role for
Rgg. Microbiology, 2009. 155(Pt 12): p. 4123-4134.

138.

Karlsson, D., et al., Modeling the regulation of the competence-evoking quorum sensing
network in Streptococcus pneumoniae. Biosystems, 2007. 90(1): p. 211-23.

139.

Prudhomme, M., et al., Pneumococcal Competence Coordination Relies on a Cell-Contact
Sensing Mechanism. PLoS Genet, 2016. 12(6): p. e1006113.

140.

Dawid, S., M.E. Sebert, and J.N. Weiser, Bacteriocin activity of Streptococcus pneumoniae
is controlled by the serine protease HtrA via posttranscriptional regulation. J Bacteriol,
2009. 191(5): p. 1509-18.

141.

Halfmann, A., et al., Activity of the two-component regulatory system CiaRH in
Streptococcus pneumoniae R6. J Mol Microbiol Biotechnol, 2011. 20(2): p. 96-104.

142.

Mascher, T., et al., The CiaRH system of Streptococcus pneumoniae prevents lysis during
stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in
beta-lactam resistance. J Bacteriol, 2006. 188(5): p. 1959-68.

143.

Sebert, M.E., et al., Microarray-based identification of htrA, a Streptococcus pneumoniae
gene that is regulated by the CiaRH two-component system and contributes to
nasopharyngeal colonization. Infect Immun, 2002. 70(8): p. 4059-67.

144.

Hentrich, K., et al., Streptococcus pneumoniae Senses a Human-like Sialic Acid Profile via
the Response Regulator CiaR. Cell Host Microbe, 2016. 20(3): p. 307-317.

145.

King, S.J., K.R. Hippe, and J.N. Weiser, Deglycosylation of human glycoconjugates by the
sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol
Microbiol, 2006. 59(3): p. 961-74.

88
146.

Cvitkovitch, D.G., Y.H. Li, and R.P. Ellen, Quorum sensing and biofilm formation in
Streptococcal infections. J Clin Invest, 2003. 112(11): p. 1626-32.

147.

Li, Y.H., et al., A quorum-sensing signaling system essential for genetic competence in
Streptococcus mutans is involved in biofilm formation. J Bacteriol, 2002. 184(10): p. 2699708.

148.

Rodriguez, A.M., et al., Physiological and molecular characterization of genetic
competence in Streptococcus sanguinis. Mol Oral Microbiol, 2011. 26(2): p. 99-116.

149.

Zhu, B., et al., A Novel Regulator Modulates Glucan Production, Cell Aggregation and
Biofilm Formation in Streptococcus sanguinis SK36. Front Microbiol, 2018. 9: p. 1154.

150.

Pynnonen, M., et al., Hemoglobin promotes Staphylococcus aureus nasal colonization.
PLoS Pathog, 2011. 7(7): p. e1002104.

151.

Shak, J.R., et al., Novel role for the Streptococcus pneumoniae toxin pneumolysin in the
assembly of biofilms. MBio, 2013. 4(5): p. e00655-13.

152.

Nieto, C. and M. Espinosa, Construction of the mobilizable plasmid pMV158GFP, a
derivative of pMV158 that carries the gene encoding the green fluorescent protein.
Plasmid, 2003. 49(3): p. 281-5.

153.

Allegrucci, M., et al., Phenotypic characterization of Streptococcus pneumoniae biofilm
development. J Bacteriol, 2006. 188(7): p. 2325-35.

89
APPENDICES
Appendix A: Correlation of gene expression by RNA-seq and qRT-PCR

RNA extracted from cell 1hr post hemoglobin treatment was used to measure the gene
expression by qRT-PCR. The relative expression was calculated using ΔΔCt method with the
comparison of +/- hemoglobin treated samples and normalized to gyrB gene in which the
expression was not changed in the RNA-Seq analysis. The experiments were performed in
duplicates with three biological replicates. The replicates data are shown as the mean  SD.

